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Abstract
There is growing interest in the reuse of clinical data for research and clinical healthcare
quality improvement. However, direct analysis of clinical data sets can yield misleading
results. Data Cleaning is often employed as a means to detect and fix data issues during
analysis but this approach lacks of systematicity. Data Quality (DQ) assessments are a
more thorough way of spotting threats to the validity of analytical results stemming from
data repurposing. This is because DQ assessments aim to evaluate ‘fitness for purpose’.
However, there is currently no systematic method to assess DQ for the secondary analysis
of clinical data. In this dissertation I present DataGauge, a framework to address this gap
in the state of the art.
I begin by introducing the problem and its general significance to the field of biomedical
and clinical informatics (Chapter 1). I then present a literature review that surveys current
methods for the DQ assessment of repurposed clinical data and derive the features
required to advance the state of the art (Chapter 2). In chapter 3 I present DataGauge, a
model-driven framework for systematically assessing the quality of repurposed clinical
data, which addresses current limitations in the state of the art. Chapter 4 describes the
development of a guidance framework to ensure the systematicity of DQ assessment
design. I then evaluate DataGauge’s ability to flag potential DQ issues in comparison to a
systematic state of the art method. DataGauge was able to increase ten fold the number of
vii

potential DQ issues found over the systematic state of the art method. It identified more
specific issues that were a direct threat to fitness for purpose, but also provided broader
coverage of the clinical data types and knowledge domains involved in secondary
analyses.
DataGauge sets the groundwork for systematic and purpose-specific DQ assessments that
fully integrate with secondary analysis workflows. It also promotes a team-based
approach and the explicit definition of DQ requirements to support communication and
transparent reporting of DQ results. Overall, this work provides tools that pave the way to
a deeper understanding of repurposed clinical dataset limitations before analysis. It is also
a first step towards the automation of purpose-specific DQ assessments for the secondary
use of clinical data. Future work will consist of further development of these methods and
validating them with research teams making secondary use of clinical data.
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Chapter 1: Introduction
There is growing interest in the reuse of clinical data for research and clinical healthcare
quality improvement. However, direct analysis of clinical data sets can yield misleading
results (Hersh et al., 2013; C. Safran, 2014). Notably, van der Lei formulated the first law
of informatics (Van Der Lei, 1991): “Data shall be used only for the purpose for which
they were collected.” On the other hand, clinical data routinely serve multiple purposes
including clinical, billing, administrative and legal. Data quality (DQ) flaws are often
cited as one cause of these misleading results (Dentler et al., 2014; Dentler, ten Teije, de
Keizer, & Cornet, 2013; Weiner & Embi, 2009). Thus, DQ assessment is generally
recommended to prevent the hazards of data repurposing (Brown, Kahn, & Toh, 2013;
Hersh, 2007; M. G. Kahn, Raebel, Glanz, Riedlinger, & Steiner, 2012).
Once data are acquired it is difficult to change their quality (Hogan & Wagner, 1997; Van
Der Lei, 1991). However, verifying their accuracy and ability to satisfy the needs of their
intended secondary uses has the potential to increase confidence by unlocking a deeper
understanding of the dataset's strengths, weaknesses, flaws and limitations. The results of
secondary analyses can be then be interpreted in the light of this information as an
indication of their validity. This idea is analogous to the concept of statistical confidence
interval (Brookmeyer & Crowley, 1982), which has enabled the understanding of many
complex phenomena with a well-defined degree of certainty.
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There is currently no generalized method or approach to carry out such evaluation
systematically for the secondary use of clinical data. However, quality is routinely
evaluated for products taking into account their intended purpose. To ensure
systematicity, these evaluations apply quality control standards and methodologies (Dale,
2015; Evans & Lindsay, 1999; Juran, 1962; Taguchi, 1986; Walker & Gee, 2000) that
require the explicit definition of quantitative requirements. Model-driven engineering
(Schmidt, 2006) supports the definition and testing of these requirements for the
systematic and purpose-driven evaluation of software products.
In this thesis I propose and evaluate DataGauge, a framework to systematically assess the
quality of repurposed clinical datasets based on these model-driven software quality
assessment methods. I define a general process for the assessment of repurposed clinical
datasets and provide guidance for the development of DQ requirements specifically for
the secondary use of clinical data. Finally, I evaluate the ability of this framework to
catch more potential DQ issues than the current state of the art methods of systematic DQ
assessment for the secondary use of clinical data.
1.1 - The Reuse of Clinical Data: Availability, Benefits and Limitations
Unprecedented amounts of data are created every day though the recoding of clinical care
information in patient records. As a result, clinical enterprises hold large amounts of data.
For instance, it has been reported that healthcare data storage needs at Beth Israel
Deaconess Medical Center have increased approximately six orders of magnitude (i.e.,
from gigabytes to petabytes) over the past three decades (C. Safran, 2014). The HITECH
2

act of 2009 has also been a driving force for growth by providing incentives for
healthcare institutions that successfully adopted interoperability-capable Electronic
Health Records (EHR) (Blumenthal, 2010). These efforts have been fueled by the
understanding that health IT can help lower costs and increase the quality of care in
medical institutions (Jha AK, 2010). The Institute of Medicine's report defining learning
healthcare systems (Institute of Medicine (US) Roundtable on Evidence-Based Medicine,
2007) has also stimulated the secondary use of clinical data for evidence-based medicine
and healthcare quality improvement.
Benefits from the reuse of this wealth of data have been noted for several decades (Fries
& McShane, 1979; C. Safran, 1991; Starmer, Rosati, & Fred McNeer, 1974). Providing
new ways to approach evidence-based medicine, surveillance, clinical research and
clinical care quality assurance are often cited as the main benefits (Guyatt G, Cairns J,
Churchill D, & et al, 1992; Hersh, 2007; Charles Safran et al., 2007). Other applications
include cohort analyses to determine readmission risk (Phillips, Safran, Cleary, &
Delbanco, 1987); description of patient populations (Hansell, Hollowell, Nichols,
McNiece, & Strachan, 1999; Herrmann & Safran, 1992); infection control and
epidemiological monitoring (C, Kp, & W, 1994; Classen & Burke, 1995; Samore,
Lichtenberg, Saubermann, Kawachi, & Carmeli, 1997); and discovery of pharmacoepidemiological relationships (Brownstein, Sordo, Kohane, & Mandl, 2007; Chalasani,
Aljadhey, Kesterson, Murray, & Hall, 2004; Herzig SJ, Howell MD, Ngo LH, &
Marcantonio ER, 2009). An additional benefit is that, like other forms of retrospective
research, the reuse of clinical data has the potential to yield valuable insights at very low
3

cost and extremely short time. Because they do not require patient recruitment or data
collection, the research is reduced to the time of data extraction plus analysis.
However, repurposed clinical data have many limitations (Hersh et al., 2013). Issues such
as inaccuracy (Hogan & Wagner, 1997), incompleteness (Nicole G. Weiskopf, Rusanov,
& Weng, 2013), bias (George Hripcsak, Knirsch, Zhou, Wilcox, & Melton, 2011), coding
standard inconsistencies (George Hripcsak, Knirsch, Zhou, Wilcox, & Melton, 2007),
inaccessible data (e.g., clinical notes) (George Hripcsak et al., 1995), heterogeneity (De
Lusignan et al., 2011) and clinical workflow influences on data recording (George
Hripcsak, Albers, & Perotte, 2011) have been reported in the literature. Dentler et al.
clearly showed the impact of these issues by attempting clinical quality indicators
calculations directly from EHR data (Dentler et al., 2014). They found that only three out
of eight quality indicators could be computed directly from repurposed clinical data due
to an average record completeness of 50% and average correctness of 87%. These
limitations have also been reported in the literature for decades. For example, a metaanalysis of data accuracy assessments on EHR data published in 1997 revealed highly
variable results (Hogan & Wagner, 1997) (e.g., accuracy measurements varying from 44
to 100%). These results clearly reveal the limited reliability of repurposed EHR data and
strongly caution against their direct reuse for purposes other than patient care. Such
findings motivated van der Lei, in 1991, to formulate the first law of informatics (Van
Der Lei, 1991): “Data shall be used only for the purpose for which they were collected.”
By definition, secondary use violates this law, making it is necessary to assess whether
clinical data are adequate for any intended purpose other than the original.
4

1.2 - Ensuring Analytical Validity Through Data Checking
Current practices suggest the use of data cleaning methods to ensure reliable results
(Broeck & Fadnes, 2013). The data cleaning process happens as the analysis is carried
out and aims to detect faulty data. Data cleaning happens in three steps: (1) Screen for
anomalous data, (2) Diagnose possible issues and (3) Address the issues found. The
screening step consists in detecting a lack or excess of data, screening for outliers,
inconsistencies, "strange" patterns and suspect analytical results (Van den Broeck,
Argeseanu Cunningham, Eeckels, & Herbst, 2005). The cleaning process is designed as a
response to issues and discrepancies found during analysis rather than a preventative
assessment procedure. Thorough checks are rarely done before the analysis in practice,
which carries the risk of missing harmful issues. In this setup, only the issues detected by
the analyst through dataset manipulation and analysis are addressed. This does not ensure
that the assessment will cover all potential threats to the validity of analytical results in
secondary use applications. For example, EHR-extracted clinical datasets may present
issues such as missing and duplicate data appearing during the extraction process, which
typically involves complex queries. Despite these potential problems, the data are rarely
checked thoroughly for quality during the extraction process. Also, data cleaning is often
driven by the purpose-independent application available testing tools (e.g., range
checking, data validation and data format checking) rather than to detect potential threats
to analytical results. This situation is much more alarming in the case of repurposed
clinical data (Van Der Lei, 1991) because they are not specifically designed and recorded
to satisfy secondary analytical needs. In such cases, issues may arise beyond the accuracy
5

and cleanliness of the data, such as not having the right variables to run the analysis or
data that record implausible events. It is, therefore, imperative to conduct a systematic
assessment of the data's suitability for a specific secondary use case prior to the
secondary analysis (e.g., statistical analysis, exploratory visualization, etc.). Thus, data
assessments of repurposed clinical data must cover a broad spectrum of potential issues
rather than only those detected by the analyst.
DQ assessment (Maydanchik, 2007a) is an alternate approach to data cleaning. Its goal is
to help ensure valid analytical results through the evaluation of the dataset's ability to
satisfy analytical needs (i.e., its fitness for purpose) (Holve, Kahn, Nahm, Ryan, &
Weiskopf, 2013; Juran, 1962). This approach is usually carried out before performing the
secondary analysis and the results serve as the basis to determine the dataset's strengths
and weaknesses. It emphasizes the evaluation of the dataset for a specific application and
is a more appropriate way of investigating a broader range of potential issues as
compared to data cleaning. This approach is also very attractive for the secondary use of
clinical data given that two purposes interact in such applications (Floridi, 2013): the
primary purpose (i.e., recording the care of patients) and the secondary analytical purpose
(e.g., prevalence estimation, clinical outcomes analysis, etc.). DQ assessments allow the
user to evaluate whether the dataset will be good enough to provide reliable results for
the secondary purpose, while still minding the primary purpose.
Kahn et al. (M. G. Kahn et al., 2012) recently proposed a generalized framework to
support a comprehensive and systematic approach to assess DQ for the purpose of
building EHR-based Clinical Data Warehouse (CDW). However, there is a second stage
6

where systematic approaches for the assessment of DQ are currently unavailable. These
assessments aim to evaluate a subset of the CDW selected for a secondary analytical
purpose (i.e., the analytical dataset). They typically focus on the independent and
dependent variables directly related to the research question. A review of methods
available for these secondary assessments (Nicole Gray Weiskopf & Weng, 2013)
revealed that current methods are not generalizable, not systematic and fail to take the
secondary analytical purpose into account. Moreover, it has been noted that one of the
main barriers to the effective assessment and the transparent reporting of DQ results in
secondary uses of clinical data are the ambiguity of DQ definitions (N. Weiskopf,
Hripcsak, Swaminathan, & Weng, 2013) and the lack of a universally accepted set of DQ
features to test for (M. Kahn et al., 2015). Making DQ requirements explicit would
greatly support consistent DQ evaluations as well as clearer communication and reporting
of DQ results.
To address the current limitations in these methods I developed a framework with the
following characteristics:
•

Supports purpose-specific DQ assessment

•

Provides a DQ assessment process that is:
o Generalizable to a wide range of secondary use cases
o Systematic (i.e., executed according to a fixed sequence of steps)

•

Makes DQ requirements explicit in order to:
o Improve communication within the research team
o Promote transparent reporting of DQ issues
7

1.3 - Dissertation Structure
To create such framework I developed a purpose-specific DQ assessment process (i.e.,
DataGauge) that possesses the features stated above, along with a guidance framework
for the development of comprehensive DQ assessments of repurposed clinical datasets.
Then, I evaluated DataGauge’s ability to increase the number of DQ potential issues
found before assessment. The dissertation is laid out in an analogous fashion. In Chapter
2, I present a review of the current state of the science in DQ theory, DQ assessments at
large and DQ assessments for the secondary use of clinical data to show current needs
and gaps in the literature. In chapter 3, I describe the DataGauge process and its
development. In chapter 4, I detail the development of the DQ assessment guidance for
the definition of DQ requirements within DataGauge. In Chapter 5, I evaluate
DataGauge's ability to identify more DQ issues than the current systematic standard
method of DQ assessment for the secondary use of clinical data. The dissertation
concludes by describing its significance and contributions to the field of clinical research
informatics and clinical data reuse.
1.4- Summary of Contributions
My work lays the practical foundation for the systematic DQ assessment of repurposed
clinical data as an evaluation of fitness for purpose (Holve et al., 2013). This contributes
to supporting the reliable secondary use of clinical data (Charles Safran et al., 2007)
which is a critical step towards building learning healthcare systems (Institute of
Medicine (US) Roundtable on Evidence-Based Medicine, 2007). DataGauge provides a
8

stronger foundation for research aiming to learn from existing clinical data, generate
novel yet data-driven research hypotheses and carry out cost-effective population-level
analyses. It also provides guidance to support a thorough definition of DQ requirements
for the secondary use of clinical data, which is currently missing in the literature. Lastly,
it provides a method to explicitly define and encode DQ requirements. This is a first step
towards supporting communication within the analytical team, because the process
provides a tangible set of documents to help organize the team member's diverse
backgrounds and expertise with respect to the secondary use case.
This work innovates by breaking the current paradigm of data assessments for clinical
data reuse, which is that ad-hoc, analyst-based, analysis-independent cleaning of data is
sufficient to prevent misleading results in the reuse of clinical data. DataGauge proposes
a new frame where repurposed datasets are to be assessed for their adequacy to answer a
specific research question prior to analysis. DataGauge also stipulates that the
assessments should be done by a team of experts in the domains of data science, statistics
and medicine. This work supports cancer prevention by enabling a more trustworthy
reuse of observational data from a broadly available yet still untapped data source:
Electronic health records. EHRs are a very powerful source of knowledge that has the
potential to enable the cost-effective analysis of population-level data. These databases
will undoubtedly become an invaluable source of data for research fields such as cancerprevention in the near future due to the increasing number of recorded variables and
imminent inclusion genomic data.
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Chapter 2: Related Work
Many tools are available for the secondary analysis of data but there are limited options
to assess whether those data will yield valid results. To ensure that analytical valid
results, one must ensure that the data accurately describe the observed objects and that
they are likely to contain the necessary information (e.g., values, variables, sampling rate,
etc.) to answer research question. Research shows that repurposed clinical data sources
pose problems in both of these areas. These problems stem from measurement and
recording processes (Aronsky & Haug, 2000) and inadequacies stemming from
repurposing (Hersh et al., 2013). It is crucial to detect these issues before analysis in
order to provide researchers with an understanding of data limitations and, in turn, the
expected accuracy of analytical results. Such process is nothing more than the quality
evaluation of a dataset, broadly known as a DQ assessment (Maydanchik, 2007a).
2.1 - Data Quality Definitions, Frameworks and Assessment Tools
DQ has been a subject of study for several decades in fields outside biomedical
informatics (Dasu, 2013; Dentler et al., 2014, 2013; Madnick, Wang, Lee, & Zhu, 2009;
Redman, 1998, 2013; Sadiq, 2013a; Trickey, 2012). Past research on DQ has produced
definitions (Standardization, 1994), methods (Maydanchik, 2007a; Olson, 2003) and
frameworks for DQ management (Fan, 2012; Sadiq, 2013b) and improvement (Batini &
Scannapieca, 2006a, 2006c; Fan, Geerts, Ma, Tang, & Yu, 2013; Lee, Strong, Kahn, &
10

Wang, 2002; Redman, 2013; Wang & Strong, 1996). This wealth of research provides a
foundation for assessment during the data production cycle and is designed to support
database administration work. In fact, most of this knowledge is geared towards
supporting the maintenance of enterprise databases through DQ management (Redman,
2013). This process entails the systematic assessment of whole databases according to
user-defined rules (Maydanchik, 2007a) and flagging of common data issues such as
duplicates and inconsistent input. Flagged data are then corrected using imputation
methods or eliminated (Fan, 2012). The cycle is repeated to monitor and manage the
quality of whole databases (Sadiq, 2013b). Though this research supports primary
practical uses of data, it provides very little guidance for the assessment of repurposed
clinical data.
Quality is defined as the ability to satisfy needs (Standardization, 1994). Those needs are
defined by an intended purpose. Thus, the most widely accepted definition of DQ is
'fitness for purpose' (Holve et al., 2013; Juran, 1962). Three key features can be derived
from this view of DQ. First, the quality of any dataset can only be measured with respect
to a specific purpose. For example, a pre-Copernican, astronomical book would have
very low DQ for its original purpose of understanding the laws governing the universe,
but very high DQ for the secondary purpose of understanding the historical development
of Ptolemaic astronomy (Floridi, 2013). Second, when repurposing data two purposes
must be considered (Floridi, 2013): the original purpose for which the data were
produced and the secondary purpose, which generally entails a secondary analysis to
answer a specific research question. This means that the assessment for the secondary
11

purpose will necessarily have to take the initial purpose into account to define
assumptions, expectations and evaluation parameters for the DQ assessment. Finally,
systematically assessing quality in any industry or application requires a set of points of
interest or DQ criteria. These criteria are represented by DQ requirements, which define
specific conditions that the dataset must meet to be fit for purpose (Juran, 1962;
Standardization, 1994). For example, the set of DQ requirements for assessing the quality
of clinical data for treating individual diabetic patients is quite different from that needed
when assessing the same data for the purpose of understanding the efficacy of a new
diabetes treatment protocol. Routine clinical data from individual diabetic patients lacks
randomization, controls, and systematic data collection. Thus, DQ requirements should
aim to define the ideal dataset for the intended purpose as a way to provide a standard to
evaluate whether the data possesses the necessary features, such as an evenly sampled
population, to obtain valid and acceptably reliable results.
In practice, DQ assessments are carried out using a set of tools and techniques that aim to
test for specific DQ issues. A large number of techniques are available in the literature to
semi-automatically assess specific DQ issues (Borek, Woodall, Oberhofer, & Parlikad,
2011; Maydanchik, 2007b). We will call these techniques DQ tests and define them as a
tool, algorithm, approach or strategy employed to test the adherence of a dataset to a
specific DQ requirement. They serve as a means to gather evidence of a dataset's fitness
for purpose in light to a specific DQ criterion. Since these tests are geared towards
identifying discrete problems, they are only capable of detecting issues at the data level
such as typos, erroneous formatting or outliers. This output is useful to flag low-level
12

problems but rarely provide enough information on their own to decide whether a dataset
is fit for purpose. This is why a DQ assessment can be defined as a judiciously selected
combination of DQ tests based on DQ requirements to assess a dataset's fitness for a
specific analytical purpose based on domain knowledge, data science, research design
and analytical tools (e.g., statistical methods, machine learning algorithms, visualizations,
etc.).
Designing DQ assessments in an effective and reliable way is a challenging task because
of the broadness of the question at hand: "Is this dataset good enough to yield valid
results when analyzed to answer the research question?" To support this design process
the literature provides frameworks that organize DQ knowledge and testing approaches
(Batini & Scannapieca, 2006a, 2006b; M. G. Kahn et al., 2012; Lee et al., 2002; Madnick
et al., 2009; Maydanchik, 2007a). One example is Wang & Strong's conceptual
framework of DQ (Wang & Strong, 1996), which describe all aspects of DQ (i.e., DQ
dimensions) that may be of interest to data consumers and classifies them into a
taxonomy (see section 3.2.3 for full description). This work provides a list of aspects that
should be considered to when evaluating DQ but the list is too abstract to be useful in
domain-specific applications (Floridi, 2013; Nicole Gray Weiskopf & Weng, 2013).
Another example is Borek et al.'s classification of DQ assessment methods (Borek et al.,
2011). This framework organizes DQ testing approaches according to target DQ
problems and database mapping requirements (i.e., data model subsets) as a way to
support systematic selection (see section 3.2.3 for full description). This framework is
helpful in three ways. First, it gives a limited list of potentially testable DQ issues and
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provides clear testing approaches. Second, it helps to break down the complexity of the
dataset into more manageable pieces. Third, by linking DQ issues and data pieces to a
finite number of testing methods, it limits the scope of the DQ assessment design. For
example, if we were to do a single variable check we could only use range checking, data
validation, lexical analysis or column analysis according to this classification (Borek et
al., 2011). Based on this limited set of methods it is much easier to select the correct
method. However, this framework does not interface with Wang & Strong's DQ
dimensions and does not provide any domain-specific support. In general, the available
guidance lumps domain-knowledge-specific DQ test definition into a 'business rule
definition' task that provides no clear process to follow (Maydanchik, 2007a). This setup
fails to support the systematic definition of DQ tests because it provides no specific
structure execute the task, leaving domain experts are to handle this task ad hoc. Also,
DQ testing approaches (i.e., DQ test tools classifications) that aim to evaluate purposespecific issues are usually represented under the umbrella terms 'Domain Analysis' and
'Semantic Profiling' (Borek et al., 2011) but fail to define them in specific terms. This
guidance ultimately does not ensure the systematic and thorough definition of DQ tests to
support systematic and thorough definition of purpose-specific DQ assessments.
Thus, current DQ frameworks are still difficult to use for DQ assessment design and
execution for three major reasons. First, there are large conceptual gaps between DQ
theory and practice (Floridi, 2013). Second, major discrepancies and incompatibilities
between nomenclature and DQ frameworks have been reported (Floridi, 2013; Nicole
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Gray Weiskopf & Weng, 2013). Finally, the guidance tends to be abstract in nature and
lack domain-specificity (Floridi, 2013).
2.2 - Data Quality Assessment for the Secondary Use of Clinical Data
It is well known that EHRs often contain inaccurate data and that accuracy varies
between sites (Hogan & Wagner, 1997). It is also broadly accepted that clinical data are
incomplete (N. Weiskopf et al., 2013). This has been partially attributed to variable
execution in data entry workflows as well as limited integration between healthcare
institutions (Finnell, Overhage, & Grannis, 2011; Parsons, McCullough, Wang, & Shih,
2012), so EHR data may not tell the patient's whole story. Also, some data contained in
the record may not be easily accessible (e.g., clinical notes) (George Hripcsak et al.,
1995). The data may not be recorded at regular intervals or at a satisfactory rate for the
secondary analysis (N. Weiskopf et al., 2013). Since EHR data is not intended for
research, coding may not be sufficiently complete or accurate for research purposes
(Bernstam, Herskovic, Reeder, & Meric-Bernstam, 2010; George Hripcsak, Knirsch, et
al., 2011). Ultimately, the root of the problem seems to be that clinical data are created as
a byproduct of clinical practice and therefore, may not follow the same production quality
standard as research staff would for a clinical research project (Hersh et al., 2013). All
these issues are symptoms of poor DQ with respect to research. Therefore, it is crucial to
carry out thorough assessments to detect DQ issues before analysis and to consider
identified issues when interpreting the analysis results.
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Current DQ assessment methods have several limitations in the field of biomedical
informatics. A recent systematic literature review (Nicole Gray Weiskopf & Weng, 2013)
found that they are not systematic or generalizable and fail to adopt the preferred 'fit-forpurpose' approach (Holve et al., 2013). They also fail to support the transparent reporting
of DQ assessments results (M. Kahn et al., 2015). Even though general DQ testing
approaches found in the literature can be applied to the secondary use of data (Borek et
al., 2011; Maydanchik, 2007b), their disparate nature and data-level (as opposed to
purpose-level) focus makes them inappropriate to support the evaluation of fitness for
purpose (M. Kahn et al., 2015; M. G. Kahn et al., 2012; Wang & Strong, 1996; Nicole
Gray Weiskopf & Weng, 2013). To address this limitation, Kahn et al. have developed a
framework, based on existing strategies and DQ tests, (M. G. Kahn et al., 2012) that
supports the assessment of DQ for repurposed clinical data. This framework provides a
process to run evaluations paired to a list of DQ rule-types to be considered by database
administrators and researchers to define DQ requirements combined into a standard to
detect poor quality data. Quality is assessed in relationship to the defined DQ standard by
flagging the data that infringes on the defined DQ requirements. This process and DQ
requirement development guidance sets the foundation for a generalized DQ assessment
for cross-site aggregation of clinical data. Though this initial framework increases the
potential for systematization for clinical data reuse, it is heavily oriented towards the
initial data production purpose (i.e., health record keeping) and does not consider an
analytical reuse purpose (e.g., answering a research question). This means that this
framework does not allow the user to assess fitness for purpose if the intended data use is
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anything but data aggregation. For these secondary purposes, there are immensely large
numbers of possible research questions to be considered, which complicates the
definition of a general framework and systematic process to assess DQ.
In response to the incoherent definition of DQ testing approaches and discrepancies
between frameworks, an ontology for the DQ assessment of repurposed clinical data has
also been recently published (Johnson, Speedie, Simon, Kumar, & Westra, 2015). This
work rigorously defines concepts to enable the automated computation of DQ measures
(i.e., quantitative evidence of DQ requirement infringements within a given dataset for a
specific purpose) through the application of DQ tests. It also defines relationships
between DQ dimensions and 19 DQ measure types that aim to unambiguously define and
catalog all possible DQ tests for the secondary use of clinical data. However, this work
has several limitations in supporting the effective DQ assessment of repurposed clinical
data. First, it does not provide a general process for the systematic execution and
implementation of DQ assessments. Second, it fails to provide guidance as to how to
develop DQ assessments that ensure a reliable evaluation of fitness for purpose. Third, it
fails to bridge the gap between purpose, DQ theory and domain knowledge for the
definition of the DQ requirements. This step is crucial to DQ assessments because it
informs the calculation of the DQ measures through the selection and definition of
specific DQ requirements that, in turn, define the DQ tests. Beyond DQ dimensions and
theory, the definition of DQ requirements depends on two information sources: (1)
purpose, which is difficult to model due to its great variability and (2) the domain
knowledge held by the experts conducting the research, which is difficult to fully include
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in an ontology. Though the ontology includes placeholders for these parameters, it fails to
provide any guidance on how to integrate and use them in practice.
2.3 - Requirements for the Definition of a DQ Assessment Framework for the
Secondary Use of Clinical Data
Effective DQ assessment depends on the purposeful combination of DQ tests (and, thus,
the definition of DQ requirements) to assess fitness for purpose. In fields outside
biomedical informatics, definition of DQ requirements has proven challenging and
frameworks have been used to support the design of such assessments (Fan, 2012; Lee et
al., 2002; Madnick et al., 2009; Stvilia, Gasser, Twidale, & Smith, 2007; Wang & Strong,
1996). A framework is currently available to support DQ assessments for the
consolidation of multi-site clinical data into CDWs (M. G. Kahn et al., 2012). However,
there is no framework to support DQ assessments for secondary analyses of clinical data.
Given the current state of the science, such frameworks should at least (1) provide a
generalizable and systematic method for assessing DQ consistently across datasets and
purposes (Nicole Gray Weiskopf & Weng, 2013) and (2) support the purpose-specific
assessment of repurposed data (Holve et al., 2013). In other words, the framework should
encourage the definition of requirements and tests that evaluate the appropriateness of
datasets for the research question at hand. Moreover, the necessity of a systematic
approach to these assessments requires a unified yet general way to define and implement
DQ assessments. Therefore, the framework must provide an unambiguous process to
define and execute DQ assessments.
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One additional limitation of current clinical data reuse practices is the tendency not to
include detailed DQ assessment results in publications (N. Weiskopf et al., 2013; Nicole
Gray Weiskopf & Weng, 2013). To address this, DQ assessment result reporting
guidelines have been published (M. Kahn et al., 2015). These aim to promote
transparency in published analyses through explicit reporting of employed DQ
assessment methods and DQ results. The ultimate goal is to ensure a deeper, more precise
understanding of repurposed clinical data limitations and, in turn, the analytical results.
Defining all parameters and assumptions of the DQ assessment explicitly would facilitate
the transparent reporting of DQ results in three ways. First, it would promote the
unambiguous definition of DQ features to test. Second, it would promote the organized
development of the DQ test lists, which would then facilitate the conversion into a
publishable format. Lastly, using explicit DQ assessment documents would structure
communication within the research team.
Thus, a framework that addresses the current limitations of DQ assessments for the
secondary use of clinical data should have the following characteristics:
•

Supports purpose-specific DQ assessment

•

Provides a DQ assessment process that is:
o Generalizable to a wide range of secondary use cases
o Systematic (i.e., executed according to a fixed sequence of steps)

•

Makes DQ requirements explicit in order to:
o Improve communication within the research team

o Promote transparent reporting of DQ issues
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Chapter 3: DataGauge - A Model-Driven Process for the Systematic Assessment of
Repurposed Clinical Data
In this chapter, I present DataGauge, a generalized and systematic procedure for the
analysis-specific assessment of DQ for repurposed clinical data that addresses the
limitations in the state of the science reviewed in Chapter 2. I also present an example
showing its uses and advantages. Finally, I discuss DataGauge's strengths and limitations.
DataGauge consists of three stages: (1) Scope definition, (2) DQ specifications
development and (3) Data processing according to these DQ specifications. DataGauge
provides specific steps that can be applied consistently across analyses to promote the
systematic assessment of DQ. It supports the purpose-specific assessment of DQ by
generating DQ requirements and documentation specific to a particular research question.
DataGauge relies on explicit standards and documentation, which promotes collaborative
analysis by providing tools to structure communication within the analytics team and in
published results. It also allows an iterative approach where the analytical scope and DQ
standards are improved as the research progresses. Finally, DataGauge facilitates linking
of DQ requirements to available assessment methods.
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3.1 - Adapting a Model Driven Quality Assessment Process to Clinical Data
Quality assessment methods are widespread in many domains outside biomedical
informatics and usually address one or more of the needs stated in Chapter 2. Basic
quality assessments rely on qualitative evaluations (e.g., satisfaction surveys), that
provide measures of perceived quality (Nelson & Niederberger, 1990). This type of
assessment is generally purpose-driven and developed based on a generalized set of
guidelines (Gómez, 2009) to ensure validity. However, such approaches have a tendency
to produce ad-hoc evaluations rather than systematic assessments. To counteract this,
standards organizations such as the ISO have defined quality control standards (Walker &
Gee, 2000) and methodologies (Dale, 2015; Evans & Lindsay, 1999; Juran, 1962;
Taguchi, 1986) that require the definition of quantitative requirements and a systematic
approach to test them. These standards require explicit design documentation that defines
quality requirements to be met by the evaluated product. One particularly interesting
research field that resulted from the creation of these engineering standards is modeldriven engineering (Schmidt, 2006). This field focuses on developing methods to support
the explicit definition of formal requirements and their automatic evaluation. These
model-driven methods enable the systematic, generalizable and purpose-driven quality
assessments of software products based on explicitly defined quality requirements. Thus,
this approach addresses similar challenges to those described in Chapter 2 for the quality
assessment of software products. However, it has not yet been adapted to assess the DQ
of repurposed clinical data, nor evaluated.
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Model-driven software development and quality assessment is a well-developed branch
of software engineering (Boytsov & Zaslavsky, 2013; Jordi Cabot, 2012; France &
Rumpe, 2007; González & Cabot, 2014; Mayrand & Coallier, 1996; Whittle, Hutchinson,
& Rouncefield, 2014). These similarities offer a unique opportunity to adapt these
methods to the DQ assessment of repurposed clinical data. Beyond addressing the
limitations of the current state of the science, translating these methods is advantageous
because model-driven quality assessment methods follow the standards for systematic
product quality control (Evans & Lindsay, 1999; Juran, 1962; Taguchi, 1986), which has
proven useful in other fields. The adaptation of these methods is likely to be viable for
two reasons: (1) Wang has shown that data can be evaluated for quality just like any other
product (Wang, 1998) and (2) experimental model-driven approaches to data validity
checking have been reported as successful in the context of structured data using finite
state models (Mezzanzanica, Boselli, Cesarini, & Mercorio, 2011).
To define such a process I assessed the commonalities between model-driven software
quality assessment methods. The methods shared three high levels stages: (1) Evaluation
of needs and scope definition (France & Rumpe, 2007; Kan, 2002; Mayrand & Coallier,
1996), followed by (2) Explicit modelling of product specifications (i.e., the quality
requirements) based on the needs (France & Rumpe, 2007; Kan, 2002; Mayrand &
Coallier, 1996; Mezzanzanica et al., 2011; Whittle et al., 2014) and, finally, (3)
Evaluation of the product based on the previously-defined requirements (Boselli,
Cesarini, Mercorio, & Mezzanzanica, 2013; France & Rumpe, 2007; Kan, 2002;
Mayrand & Coallier, 1996; Mezzanzanica et al., 2011). These three steps can be easily
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adapted to the secondary use of clinical data as the following stages: (1) A data needs
assessment that serves as a definition of the data scope and should include the analysis of
the research question and a definition of the resulting data needs, (2) The specification
development, which would include the specification of the data needs in an explicit
model as well as the definition of DQ requirements and, finally, (3) the evaluation, which
would entail the assessment of the data according to the DQ requirements.
At the heart of this process lies the definition of explicit models to represent DQ
requirements. Multiple languages are used to describe such requirements in model-driven
software quality assessment. For example, Universal Modelling Language (UML) and the
Object Constraint Language (OCL) are routinely used to define software requirements.
(J. Cabot, Clariso, & Riera, 2008; Jordi Cabot, 2012; Jordi Cabot & Gogolla, 2012;
Demuth & Hussmann, 1999; Pinet et al., 2011; Selic, 2004; Zubcoff, Pardillo, & Trujillo,
2009). UML is also routinely used to describe databases and data models in practice
through its entity-relationship diagrams (Selic, 2004). OCL is designed to fully integrate
with UML and provides an additional layer of constraints on data models (Jordi Cabot &
Gogolla, 2012). The combination of these two languages is a viable way of encoding DQ
requirements in a standardized, unambiguous way, resulting in a unified DQ assessment
specification model-based document.
To refine this initial process for the DQ assessment of repurposed clinical data I carried
out three assessments of repurposed clinical data. The end result was a generalized
process for the systematic DQ assessments based on UML entity-relationship diagrams
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and OCL constraints that I have named DataGauge. The process is presented in the next
section.
3.2 - The DataGauge Process
3.2.1 - Method overview
Figure 1 illustrates the three stages of the analysis-specific DQ assessment method called
DataGauge. The stages are: (1) Data Need and Scope definition, (2) DQ specifications
development, and (3) Data processing according to these specifications. These three
stages are composed of five steps: (1) Define needs based on the research question and
analytical study design, (2) Develop a data needs model (DNM) where we formalize the
data needs, (3) Develop analysis-specific DQ requirements based on the analytical
purpose, the DNM and the dimensions of DQ, (4) Extract data from the source dataset to
fit the DNM, and (5) Evaluate the extract according to the DQ requirements where we
flag all data that infringes on the DQ assessment standard.
DataGauge is a guide for DQ assessments that applies to most secondary uses of clinical
data. It is designed to be carried out collaboratively by a team of domain experts (e.g.,
clinicians), data users (e.g., researchers, clinical personnel, etc.), informaticians,
statisticians, and database administrators (Barlow, 2013). Such a team ensures input from
all relevant perspectives. The team is expected to iterate over these steps several times to
refine the specifications as the research progresses.
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Stages

Steps
1- Research Ques-on
Analysis

1- Scope
Deﬁni-on
2- Data Needs Model
Development
Iterate

Speciﬁes

3- Data Processing

3- Analysis-speciﬁc DQ
Requirements Development

Speciﬁes

2- Speciﬁca-on
Development

4- Data Extrac-on and
FormaDng

5- DQ Evalua-on

Figure 1 – Iterative analysis-specific DQ assessment method for the secondary use of
clinical data. This process defines the general stages and steps for analysis-specific DQ
assessment using data models and an analysis-specific DQ standard.

3.2.2 - Stage 1: Data Scope Definition
The initial stage defines the scope of research in terms of data. This is done in two steps.
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Step 1: Research Question Analysis
First, the domain expert and statistician must define the research question and analytical
design. This dictates the data needs. Objects of relevance to the analysis are identified
(e.g., patients, prescriptions, diagnoses, etc.) along with independent and dependent
variables based on the research question (Tabachnick & Fidell, 2001). I define data needs
as all variables and metadata necessary to achieve the analytical goal (i.e., answering the
research questions). For example, if we are studying the relationship between weight and
age, the domain expert will define a person object that will contain the necessary patient
demographic variables (i.e., weight measurements and age) plus all additional covariates
to be selected based on their analytical needs and clinical domain knowledge.
Step 2: Data Needs Model Development
The second step is to build a Data Needs Model (DNM) that defines the ideal analytical
dataset. We define the DNM as a fully-specified, explicit representation of all data needs
for the analytical purpose, including the relationships between data elements. For
example, if we are investigating relationships between weight and age, a simplistic DNM
may be defined as a single table containing 'Subject ID', 'Weight' and 'Age' variables,
where each line represents a weight observation. The model serves as a design
specification document and an unambiguous means of communication among team
members. This model defines the scope based on analytical requirements. This marks the
end of stage 1 that ensures agreement on the scope of work, the necessary data and its
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context for a specific analytical purpose. Step 2 continues into the first part of stage 2,
described next.
3.2.3 - Stage 2: Specification Development
The second stage consists of iteratively refining the DNM along with DQ requirements
that, if met, would ensure fitness for purpose. These two elements fully specify a DQ
assessment for a clinical data source and a specific analytical purpose. Step 2 concludes
when the analytics team has a fully defined and is satisfied with the DNM version. The
qualities of a satisfactory DNM are difficult to define generically because they heavily
depend on the purpose. The experts in the analytics team must, therefore, decide when
the DNM is ready. It is important to note that it may be useful to run additional iterations
of the DataGauge process after the initial evaluation. The DNM can then be revised and
further refined.
This step is crucial for several reasons. First, it clearly defines the assessment scope.
Second, it defines the object(s) of analysis fully and explicitly. Third, the DNM defines
the variables and their relationships, but also assigns clinical meaning to them by
grouping them into objects that make clinical sense such as patient, prescription and
measurements. This provides a link between the source data, the analytical purpose and
clinical domain knowledge. Revisiting the weight and age relationship example, the
'Patient ID' would be an identifier with no specific clinical meaning, but 'Weight' would
be tied to an observation that is associated with an office visit in the medical record. The
additional clinical workflow information allows the analytics team to relate the weight
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variable to clinical domain and workflow knowledge. Defining the DNM also supports
the generation of DQ requirements by outlining a finite DQ evaluation space. For
example, if there are no numerical variables in the data model, the team will not have to
set numerical thresholds for range checks. To ensure systematicity, the DNM design
should also be in at least third normal form (Kent, 1983) or, equivalently, follow a tidy
data format (Wickham, 2014). Although equivalent, we prefer the tidy data standard,
because it defines the data format in terms that are easier for analysts and researchers to
understand. These forms specify the observational units (modeled as different tables), the
variables within a unit (columns of a table), and the observations of each unit (rows of a
table), that allow the clear definition of data needs. An example of tidy-data-compliant
DNM is provided in the next section. A clear specification of these three elements is
required prior to beginning step 3.
Step 3: Analysis-specific DQ requirements Development
Once the analytics team has fully defined the DNM, the third step is the definition of an
analysis-specific DQ standard composed of DQ requirements. I define the DQ standard
as a document containing the full set of individual DQ requirements that fully describe a
fit-for-purpose dataset for a specific research question and DNM. This document allows
the analytics team to explicitly develop and agree on DQ for a particular case. The
development of DQ requirements is task is complex because it requires the integration of
multiple information sources (e.g., the DNM, the research question, DQ theory). To tease
out this complexity, I first lay out the theoretical basis for the DQ requirement
development in the next paragraphs as follows: (1) define DQ requirements by
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differentiating them from inclusion/exclusion criteria, (2) explain how developing tidydata-compliant models helps the analytics team to tease out the DNM's complexity and
make the variables of interest more accessible, (3) I then explain how the levels of data
granularity (Oliveira, Rodrigues, & Henriques, 2005) contribute to a thorough definition
of DQ requirements and lastly (4) I explain the role of the DQ dimensions (Wang &
Strong, 1996; Nicole Gray Weiskopf & Weng, 2013) and their integration into the DQ
requirement generation task. The last paragraph of this section describes the DQ
requirement development procedure.
I differentiate DQ requirements from inclusion/exclusion criteria by the object they
define and their goal. Inclusion/Exclusion criteria focus on the main object of interest to
the research question (e.g., patients, encounters, visits, prescriptions, etc...). They aim to
define the features that qualify or make these objects unacceptable for the study. These
criteria aim to define a cohort or population. For example, if patients are the objects of
study, inclusion/exclusion criteria will be based on demographic and clinical
considerations. The object of analysis will usually be a patient for clinical research
question but may also be encounters, visits, clinical notes, etc. for quality improvement
and other projects. On the other hand, DQ requirements define the minimum expectations
of data to ensure that a specific dataset is valid and useful for a specific analytical
purpose. They aim to define a fit-for-purpose dataset. For example, "patient is at least 18
years old" is an inclusion criterion whereas "patient date of birth is earlier than
observation date" is a DQ requirement. Each DQ requirement corresponds to a DQ test
that will be carried out. For example, if our secondary analytical purpose included
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assessment of weight change over time, a requirement might be 'patients must have at
least two weight measurements'. To test this, I would check that there are enough patients
with at least two weight measurements in the dataset for the secondary analysis (i.e., the
dataset has an adequate sample size). If the condition is not met, the dataset is not fit for
this particular analysis.
DNMs often describe multiple aspects of a phenomenon, which can yield complex
datasets. For example, a dataset for the secondary use of clinical data may contain cohort
identification variables (i.e., variables that define patient characteristics and support their
classification), outcome definition variables, exposure variables and relevant covariates
(M. Kahn et al., 2015). To address this complexity we propose two strategies: the
development of DNMs in the tidy data format (Wickham, 2014) and the decomposition
of the DNM into levels of data granularity, described in the next paragraph (Oliveira et
al., 2005). The requirements for a tidy dataset are "each variable reside in a column",
"each observation is presented in a row" and "each type of observational unit is a table".
In such form it is easy to isolate meaningful segments of the data model that correspond
to variables and elements relevant to purpose. For example, let us build a DNM
describing the necessary data to examine the relationship between patient demographics
and patient weights over time. We may begin with a dataset that describes patients and
their weight measurements and get the data in non-tidy-data-compliant formats; for
instance, one line per weight measurements with all patient data attached to every line or
one line per patient with multiple columns for weight measures. Neither of these forms is
tidy-data-compliant because they combine two observational units in one table: patients
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and weight measurements. Each observational unit must have a separate table. This
means that we must necessarily have one table for patients and we must have a table for
weight measurements. Also, each observation must be recorded as an individual row;
this means that the database must contain one line per patient in the patient table and one
line per weight measurement in the weights table. Finally, tidy-data standards require that
each variable must be recorded in a distinct column. This means that the weights table
must record the patient identifier, the weight value, the unit, a timestamp and any
additional information as distinct columns. The same applies for the patient table where
each column would correspond to a demographic variable. In the end we would have two
tables: a patient table with all demographic variables (e.g., gender, date of birth, etc.) and
a table with weight values and additional variables as described above. These two tables
should be related to each other via a patient identifier, which plays the role of a primary
key to the patient table and a foreign key to the measurements table. This data format
makes patient demographics and weight measurement accessible for analysis and DQ
assessment.
A model with accessible variables also allows the team to view the DNM as a
combination of data elements along a scale of data granularity (Oliveira et al., 2005). I
define data granularity as the different data levels at which the objects of interest (i.e.,
patients, outcomes, drug exposures, etc.) can be encoded into the DNM. Some examples
of these levels are: single value, multiple values, observation, observational unit and
dataset. The benefits of providing a way to break down the DNM into simpler data
elements are twofold. First, it reduces the complexity of the elements to assess. Second, it
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allows the use of DQ test selection guidance. Borek et al. (Borek et al., 2011; Oliveira et
al., 2005) have mapped these levels of data granularity to DQ test methods (i.e., ways to
check the data based on DQ requirements). This mapping reduces the number of possible
tests to be applied by giving the DQ assessment designer a limited number of testing
approaches to choose from. In essence, this work maps usual DQ problems (e.g., missing
values, inconsistent data formats, incorrect values, etc.) to DQ testing approaches (e.g.,
range checking, data validation, lexical analysis, etc.), classifying their usefulness by data
granularity level (e.g., single value, multiple values, observation, etc.). This is a good
starting point for a systematic DQ assessment design strategy because it tasks the
analytics team with reviewing a finite number of data elements, for a finite number DQ
testing strategies. Its core weakness is that it does not map to DQ dimensions.
To define an assessment that evaluates fitness for purpose, it is necessary to account for
all dimensions of DQ (Wang & Strong, 1996; Nicole Gray Weiskopf & Weng, 2013).
The theoretical dimensions have been formally defined by Wang & Strong in their
conceptual framework of DQ (Wang & Strong, 1996) based on aspects that may be
important to data consumers. They fall into four distinct categories: (1) Intrinsic DQ
refers to the qualities that the data should have regardless of their purpose, (2) Contextual
DQ focuses on the qualities that the data should have, based on the purpose for which
they will be used, (3) Representational DQ includes data modeling and information
display, and (4) Accessibility DQ focuses on having data that are readily available to be
processed and yet accessible by authorized users. Intrinsic DQ encompasses accuracy,
believability, objectivity and data source reputation (Wang & Strong, 1996). These
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dimensions relate closely to the initial purpose for which the data were produced rather
than the secondary analytical purpose. On the other hand, contextual DQ relates to the
purpose for which the data are to be used. Dimensions of completeness, relevancy,
timeliness, quantity of data and added value in the context of the intended purpose
constitute contextual DQ. These dimensions are particularly useful when assessing the
fitness of a specific dataset for secondary analysis. DQ requirements should be built
around these dimensions keeping the analytical purpose in mind. In practice, the
assessment should also include data checks to ensure the accuracy and believability of
the repurposed dataset in case preliminary DQ assessments of primary purpose failed to
catch errors that may adversely impact the analysis. When combined with the DNM at
different levels of data granularity and the analytical purpose, these dimensions are the
key to a comprehensive analysis-specific DQ assessment. This will be illustrated in the
following section.
Step 3 consists of reviewing the data model at all levels of data granularity to define the
DQ requirements in terms of DQ dimensions and the analytical purpose. These
requirements are assigned to specific DQ assessment methods (Borek et al., 2011)
according to potential DQ issues and the level of data granularity (Oliveira et al., 2005).
The team surveys the DNM in light of DQ dimensions to define the minimum standard of
quality for a particular analysis. For example, if studying the relationship between patient
weight and age, the domain expert should define criteria relating to the plausibility of the
weight variable such as "weights are positive numbers", but also relating to the
completeness of the dataset such as "each patient should have at least one weight
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measurement" and so on. Each requirement will be mapped to a specific DQ checking
method based on the assessed DQ dimension and data granularity level. We provide a
table linking DQ dimensions, data granularity and DQ testing approaches to facilitate this
(Table 1). We built this guidance table as a combination of Borek's et al.'s (Borek et al.,
2011) classification of DQ testing approaches and the DQ dimensions relevant to the
secondary use of clinical data defined by Weiskopf et al. (Nicole Gray Weiskopf &
Weng, 2013) (i.e., correctness, completeness, concordance, plausibility and timeliness). I
included an additional 'representation' dimension to assess the issues of data
transformations and fit of the available data to the DNM specifications. This dimension
accounts for database design considerations being respected in the dataset (e.g., primary
and foreign key checks).
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Table 1 - DQ requirement development guidance table. This table links DQ dimensions,
levels of data granularity and DQ testing approaches as a way to provide an overview or
'menu' of the testing strategies at the disposal of the research team.
Data Quality Dimensions
Data Granularity
Levels
Cell/Value

Correctness and
Plausibility
Domain analysis,
Data Validation,
Lexical analysis

Column/Variable

Column Analysis,
Data Validation,
Semantic Profiling
Domain Analysis,
Semantic Profiling

Completeness

Concordance

Representation

Domain Analysis,
Lexical Analysis

Domain Analysis

Column Analysis,
Lexical Analysis,
Schema Matching

Domain Analysis

Column Analysis,
Domain Analysis

Column Analysis,
Data Validation

Column Analysis,
Schema Matching

Column Analysis,
Domain Analysis

Domain Analysis,
Semantic Profiling

Domain Analysis,
Semantic Profiling

Domain Analysis,
Schema Matching

Domain Analysis,
Semantic Profiling

Table/Observational Domain Analysis
unit

Domain Analysis,
Column Analysis

Column Analysis,
Semantic Profiling

Schema Matching

Semantic Profiling,
Domain Analysis

Multiple Tables/
Dataset

Semantic Profiling,
PK/FK analysis,
Column Analysis

Domain Analysis,
Semantic Profiling

Domain Analysis,
PK/FK Analysis,
Semantic Profiling

Semantic Profiling,
Domain Analysis

Multiple Databases/
Multiple Datasets

Semantic Profiling,
Domain Analysis,
Column Analysis

Domain Analysis,
Semantic Profiling

Semantic Profiling,
Domain Analysis

Column analysis,
PK/FK Analysis,
Semantic Profiling,
Schema Matching
Column analysis,
Schema Matching,
Semantic Profiling

Line/Observation

Timeliness

Semantic Profiling,
Domain Analysis

3.2.4 - Stage 3: Data Processing
This last stage uses the DNM and analysis-specific DQ standards to extract, format and
assess the data.
Step 4: Data Extraction and Fitting
The fourth step uses the DNM to guide the data extraction from the original database and
to fit the data into the format defined in the specifications. The database administrator
creates a schema with tables matching the DNM then loads the source clinical data into
the tables. This schema should have all database rules such as variable type definitions,
primary key rules, table relationship rules and other data validation triggers built in.
Using this predefined schema to load the extracted data ensures that the values match the
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agreed upon data model, variable types and database relationships. This step is an initial
representational DQ test; if the data are not in the right format or variable types do not
match, the database software should produce an error.
Step 5: DQ Evaluation
The fifth and last step consists of evaluating DQ based on the previously defined DQ
requirements. Appropriate DQ test methods (Maydanchik, 2007b) are selected and
implemented to test each DQ requirement. This process evaluates DQ standard
compliance and flags discrepancies. These flags allow further analysis, data diagnosis
and imputation (Van den Broeck et al., 2005). Several indicators (i.e., DQ measures) can
be calculated from these flags as measures of DQ (e.g., compliance percentage for each
variable or patients with no data flaws divided by the total number of patients). These
results provide quantitative evidence of non-compliant data and can serve as a basis for
experts to judge the fitness for purpose.
3.3 - Example
We used DataGauge to assess DQ for a repurposed clinical dataset and address the
challenges of analysis-specific DQ assessment. The analytical purpose was to determine
whether prednisone, a commonly-prescribed corticosteroid, is associated with weight
gain. We chose this association because weight gain is a known and clinically-significant
side effect of prednisone (PredniSONE Tablets [Package Insert], 2012) that is likely to be
detectable through retrospective review of clinical data. Our data source was a CDW
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containing routinely recorded clinical data from six academic outpatient clinics in a large
metropolitan area in the southern United States.
We used a UML-based database modeling tool (MySQL workbench data modeler; Oracle
Corp., Redwood Shores, CA) to develop the DNM. A team composed of a clinician, a
statistician and an informatician (the author), who also played the role of database
administrator, developed the final UML diagram for the research question (Figure 2c). A
series of models were iteratively created and discussed according to their ability to satisfy
the analytical purpose as well as data availability in the CDW. Note the changes that led
to the final data model in Figure 2 and the variations in DQ requirements per iteration in
Table 1. Figure 2 shows variables that were removed because they were unavailable in
the CDW (e.g., no drug exposure variable was found or could be reliably calculated from
our CDW data). Figure 2 shows the evolution of the DNM from (a) single-table format
that is not tidy data-compliant into (b) a tidy data compliant model with four
observational units (i.e., Patient, Visit, PrednisonePrescription and Weight). The final
DNM (c) improves on the tidy-data compliant model by removing the Visit observational
unit, which is not directly relevant to the research question, and adapted the model to the
data available in the CDW (e.g., changes in the variables describing the prednisone
prescription). Our final model conforms to the tidy data guidelines (Wickham, 2014)
providing one observational type per table (i.e., patients are represented as a separate
table from weights and prescriptions), each line represents an observation (i.e., each line
on the patient table a different patient, and in the prescription table a different
prescription) and each variable corresponds to a column (e.g., patientID, gender and DoB
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are separate variables in the patient table); this data format also corresponds to the third
normal form (Kent, 1983). The final DNM served as a data specification document to
guide the data extraction. Database tables were created to match the DNM and the raw
data were extracted from the source database into the DNM schema using standard SQL
queries. DQ requirements were defined in the form of Boolean expressions and Object
Constraint Language constraints (Jordi Cabot & Gogolla, 2012). We chose OCL due to
its integration with the UML diagrams previously used for the data models (Demuth &
Hussmann, 1999; J. Cabot, Clarisó, & Riera, 2014; Seiter, Wille, Soeken, & Drechsler,
2013).
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a)#

b)#

c)#

Figure 2 - Evolution of the data needs model for the purpose of assessing a relationship
between prednisone and weight gain using repurposed clinical data. This data model
defines the data needs for the evaluation of an association between prednisone and weight
gain. a), b) and c) show the three versions of the DNM for the each iteration.
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We generated DQ requirements iteratively and collaboratively. Each DQ dimension was
surveyed at different levels of data granularity (e.g., single value, multiple values,
observation, observational unit, dataset, etc. (Oliveira et al., 2005)) running through all
variables of the DNM and using the overview provided in Table 1 to guide the process.
For example, when we combined the accuracy dimension with the single value level for
the final DNM we came up with requirements such as "Dose must be positive" or "Refills
must be positive or 0"; both of these requirements were mapped to a range checking
method. The concordance dimension at the observation level yielded criteria such as "the
prescription date should be later than the patient's date of birth" which was mapped to the
semantic profiling DQ check method. At the observational unit or table level we assessed
the timeliness of the data with the "Patient has a second weight measurement within 4
months of the first prescription" requirement. This requirement was also mapped to the
semantic profiling check method. DQ requirements were generated until the analytics
team was satisfied with the DQ standard. We used the DQ requirements to evaluate the
quality of the extracted data based on the third version of the DQ standard. We covered
analysis-specific DQ requirements as well as generic requirements to test accuracy and
believability of the data. Of 52 requirements, 17 were analysis-specific. Analysis-specific
requirements tended to be more complex and concern a larger number of variables. Table
2 shows how the requirements evolved over iterations; note the increasing precision and
analysis-specificity (e.g., "2 values per patientID" in iteration 2 followed by "50%
patients with 2 weight measures within 4 months of first prescription"). Each new DNM
represented a specific data model designed to satisfy the same analytical purpose; each
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iteration for the DQ requirement created an increasingly complete, refined and analysisspecific set of requirements.
Table 2 - Data quality requirement examples. The table shows DQ requirement examples
as they were generated. The requirements became more specific and analysis-specific as
the development progressed.
Iteration

DQ Dimension

1 Accuracy
Accuracy
Believability
Accuracy
Believability
Accuracy
Believability
Accuracy
2 Accuracy
Accuracy
Concordance
Concordance
Concordance

Variable
Granularity

Variable(s)

Analysis
Specific?

Requirement

Value
Value
Value
Value
Value
Value
Value
Value
Value
Column
Line
Line
Table

Gender
WeightValue
WeightValue
Strength
Strength
Dose
Dose
Refills
WeightTime
PatientID
WeightTime, DoB
PrescDTTM, DoB
PatientID,
WeightTime,
WeightValue
PatientID,
WeightValue
PatientID,
WeightTime
PatientID,
WeightTime
Strength, Dose,
Days, Refills
Patient, PRN
PatienID,
WeightTime
PatientID,
WeightValue,
WeightTime,
PrescriptionTable
All Variables

No
No
No
No
No
No
No
No
No
No
No
No
Yes

In {'M','F','U'}
>0
<400
>0
<2*[Max dose]
>0
<2*[Max pills at min strength]
>=0
>[System Installation Date]
Unique
Timestamp>DoB
PrescDTTM>DoB
Patient weights on prescription date are less
than 2% apart

Data Validation
Range Checking
Range Checking
Range Checking
Domain Analysis
Range Checking
Domain Analysis
Range Checking
Data Validation
Column Analysis
Domain Analysis
Domain Analysis
Domain Analysis

DQ Result
(% compliance
or Pass/Fail)
99.99
92.65
99.95
97.37
100
51.68
100
100
100
100
100
100
92.45

Yes

2 weight measurements per patient

Domain Analysis

85.92

Yes

Patient has weight measurement on
prescription date
Patient has second weight measure within 4
months of prescription
Can calculate total milligrams prescribed for
50% of prescriptions
Less than 25% PRN prescriptions
50% patients 2 weight measures within 4
months of first prescription
Patients with at least 2 unflawed weights
after an unflawed prescription

Domain Analysis

97.54

Domain Analysis

48.62

Domain Analysis

Failed

Domain Analysis
Domain Analysis

Passed
Failed

Domain Analysis

13.1

Patient records with no general DQ flaw

Domain Analysis

2.93

Completeness

Table

Completeness

Line

Timeliness

Table

3 Amount of data

Table

Amount of data
Amount of data

Table
Dataset

Completeness

Dataset

All

Dataset

Yes
Yes
Yes
Yes
Yes

No

DQ assessment
method

The DQ tests revealed several DQ flaws. We were able to identify specific DQ issues
such as inaccuracies (e.g., 84 weight values were above 400kg), inconsistencies (e.g., 56
instances where weight changed more than 20% over 2 days) and incompleteness (e.g.,
43,135 patients with less than two weight measurements within 3 months of the
prescription). This showed the approach's effectiveness at catching DQ issues and
screening data at the basic data level. We also excluded 14.1% of the patient records as
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they contained a single weight measurement and weight gain can only be calculated with
two or more. We flagged all data items that violated DQ criteria and then calculated the
number of patients with no flagged data in their records, having at least two weight
measurements after their first prednisone prescription. Thus, only 2,379 patients out of
80,990 (13.1%) could be confidently used for analysis. The massive censoring of patient
records is likely to bias in the final dataset used for analysis and potentially render
subsequent analytical results unreliable. Also, in this particular case we are looking at a
commonly prescribed drug and a broad population. However, large clinical datasets are
often used to investigate features of rare diseases and specific cases for which few
patients records may qualify. This high level of censoring could drastically reduce the
sample size to levels inadequate for secondary statistical analyses.
This example illustrates how DataGauge can advance current practices in DQ assessment
for the secondary use of clinical data. First, DataGauge provides an analysis-specific DQ
assessment method. We showed a way to define DQ requirements based on the DNM,
which is dictated by the analytical purpose, but also to define them based on the intended
purpose. For example, "2 values per patientID" is a DQ requirement that depends on the
DNM, but also relevant to the analytical purpose because two weight measurements are
necessary to detect change over time.
DataGauge is general because it can be applied across cases by generating new analysisspecific DNMs and DQ standards. Second, DataGauge provides guidance for DQ
standards and tool selection by allowing a DNM to be decomposed into multiple pieces.
Paired to potential DQ issues, these pieces can be mapped to specific DQ test tools and
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standards (Borek et al., 2011; M. Kahn et al., 2015). In surveying the DNM at multiple
levels of granularity we were able to identify the DQ requirements. The levels of data
granularity informed method selection by explicitly listing and reducing number DQ tests
that could be applied. For example, if we were to do a single variable check we could
only select from range checking, data validation, lexical analysis or column analysis
(Borek et al., 2011). Based on this limited set of methods and the actual requirement it is
much easier to select the correct method.
The DNM in the tidy data format allows the research team to clearly identify variable
types (e.g., cohort definition, exposure, covariates, etc.) to organize their requirements
and results to match current DQ reporting standards (M. Kahn et al., 2015). Finally, the
application of DataGauge provides explicit documentation (i.e., a DNM and a DQ
standard) that can structure the communication among team members. These documents
can be evaluated, discussed and improved as the work progresses. The team can focus on
analytical needs and research goals to develop a model that is then refined by the
constraints of data availability.
3.4 - Conclusion
I have presented DataGauge, an iterative team-based method to carry out analysisspecific DQ assessments for the secondary use of clinical data. DataGauge requires five
steps: (1) Define needs based on the research question and analytical study design, (2)
Develop a DNM where we formalize the data needs, (3) Develop analysis-specific DQ
assessment requirements based on the analytical purpose, the DNM and the dimensions
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of DQ, (4) Extract data from the source dataset to fit the DNM, and finally (5) Evaluate
the extract according to the DQ requirements. DataGauge addresses limitations in the
state of the science of analysis-specific DQ assessment for the secondary use of clinical
data by providing a systematic and analysis-specific approach. DataGauge is designed to
be a general DQ assessment process, as its steps can be applied to any dataset and
analytical purpose. It is purpose-specific because the first two stages are dedicated to
capturing the complexities of the research question at hand and developing assessment
documents to fully specify a purpose-specific DQ assessment. These documents describe
the assessment's assumptions and parameters explicitly. Finally, DataGauge supports
systematicity because it allows the consistent definition and implementation of DQ
assessments. Variables of interest and DNMs are defined in a systematic way; however, a
systematic definition of DQ requirements would require further support due to the its
complexity (i.e., combining research question, DMN, DQ theory and domain knowledge
to define requirements).
We have provided preliminary guidance for the development of a well-defined DNM and
analysis-specific DQ requirements. This guidance combines knowledge from the
literature about the link between DQ dimensions relevant to the secondary use of clinical
data, levels of data granularity and DQ testing approaches. It provides an overview of the
general DQ dimensions to consider, data granularity levels that support the
decomposition of the DNM into more manageable pieces and provides DQ testing
approaches for each DQ dimension-data granularity level combination. This guidance is
useful because it provides a finite set of aspects to consider when developing DQ
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requirements for a specific purpose and maps them to specific testing approaches.
However, it was difficult to determine whether the definition of DQ requirements had
covered all relevant aspects. Ensuring this is critical because the efficacy of the DQ
assessment at catching DQ issues is dependent on the comprehensiveness of the DQ
standard. We have provided four preliminary guides to support the development and
testing of DQ requirements based on previous work: 1) a tidy data format organize data
models in such a way to make variables accessible (Wickham, 2014), 2) a scale in levels
of data granularity to break down the DNM's complexity (Oliveira et al., 2005), 3) a
mapping between levels of granularity and available DQ check methods (Borek et al.,
2011) and 4) the dimensions of DQ that dictate the aspects to consider when testing
fitness for purpose (Wang & Strong, 1996). DataGauge integrates prior work into a single
procedure that guides the user to explicitly define their data needs and DQ requirements.
However, there are still challenges in defining DQ requirements comprehensively. We
attribute this to three reasons: (1) The DNM, the data granularity levels and the DQ
dimensions don't fully define the problem space to define all DQ requirements, (2) the
DQ dimensions are vague (e.g., there are multiple definitions of completeness (N.
Weiskopf et al., 2013)) and (3) the DQ dimensions are too far removed from clinical
domain to be useful in secondary use applications. Thus, further work is needed to
develop domain-specific guidance for the definition of analysis-specific DQ standards.
Such work would ensure a thorough and systematic development of DQ requirements
and, in turn, more reliable DQ assessments. In the next chapter, we describe the
development of such guidance.
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Chapter 4: A Guidance Framework for the Development of DQ Requirements
DataGauge is designed to enable systematic, purpose-specific DQ assessments by
providing a general process to implement DQ evaluations across repurposed datasets and
research questions. However, the systematicity of a DQ assessment can only be fully
ensured if the analytics team is provided with a way to generate the DQ requirements
comprehensively and consistently. In fact, DQ assessments can be defined as a
judiciously selected combination of DQ tests based on DQ requirements. This means that
the definition of DQ requirements is the key component of the assessment's design.
Generating such requirements can be a daunting task because it requires integrating
multiple information sources: the research question, the DNM, DQ theory and the domain
knowledge necessary to interpret the other three elements. Though the current version of
DataGauge provides some support to address this (e.g., DQ dimensions (Wang & Strong,
1996) and a classification of DQ test approaches (Borek et al., 2011)), the generation of
DQ requirements remains a complex task. This complexity threatens the systematic
definition of DQ requirements. Thus, further guidance to support this task is needed.
There is very little literature available to guide the development of purpose-specific
requirements and the available guidance presents three key limitations: (1) the DQ
requirement generation process is not described in detail (Maydanchik, 2007a), (2) the
guidance provides no specific structure to address the task systematically, implying that
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experts should execute this task ad hoc (Borek et al., 2011; Lee et al., 2002; Wang, 1998)
and (3) purpose-specific DQ testing approaches are usually lumped under the umbrella
terms 'Domain Analysis' and 'Semantic Profiling' (Borek et al., 2011), which ultimately
don't provide transparent guidance.
A similar situation exists in biomedical informatics, where very little guidance exists to
support fitness-for-purpose assessments (Holve et al., 2013). The literature provides three
pieces of guidance. First, DQ dimensions have been adapted to the secondary use of
clinical data that provide some support (Nicole Gray Weiskopf & Weng, 2013) but
remain vague, ambiguous and removed from the clinical domain (N. Weiskopf et al.,
2013). Second, an assessment framework that provides guidance as to what types of
general checks can be performed on clinical data has been published (M. G. Kahn et al.,
2012). This guidance fails to include considerations about the purpose or the domains of
expertise that come into play when making secondary use of clinical data (Barlow, 2013).
Finally, the DQ ontology for the secondary use of clinical data (Johnson et al., 2015)
provides some insight as to which types of tests that can be used to assess fitness for
purpose. Even though, providing such list of possibilities is useful, the interplay of
complex information sources (i.e., dataset and domain knowledge) as well as the inherent
vagueness of the research purpose and DQ dimensions still make this work unlikely to
support the systematic generation of DQ requirements for a specific research question
and a specific dataset.
Three key challenges result from this state of the science; they are also relevant the
current guidance provided by DataGauge. First, the original guidance posed problems
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because it is abstract and too far removed from the knowledge domain of application. In
other words, the DQ dimensions (Wang & Strong, 1996; Nicole Gray Weiskopf & Weng,
2013), data granularity types (Borek et al., 2011) and DQ testing approaches
(Maydanchik, 2007a) do not provide any guidance about the kinds of threats that affect
data based on clinical domain or EHR data knowledge. For example, if we were assessing
concordance in weight values within a day, and detected a 30% increase, this would
clearly be a problem based on clinical knowledge (i.e., patient weights don't fluctuate that
much over the course of a day) whereas this would not be a problem if we were assessing
the systolic blood pressure measurement values; systolic blood pressure varies
considerably over a day. Current literature provides no guidance on this type of
distinction and lacks explicit structure to facilitate the detection of such issues through
the integration of expert knowledge. Second, the current guidance does not provide a
clear overview or list the aspects to be reviewed to ensure a comprehensive and
systematic generation of DQ requirements. Though DataGauge provides a limited list of
items to assess when combined with the DNM, it fails to include important dimensions
such as the expertise involved in defining DQ requirements. An overview would help the
analytics team track the coverage of DQ assessment aspects and potential DQ threats to
be considered. Though the list of DQ criteria, data types, variables in the DNM and DQ
testing approaches provided a finite list to review, it does not identify specific DQ threats
in repurposed clinical data. Finally, the DQ dimensions that aim to guide the requirement
generation are vague. For example, completeness could be interpreted in multiple ways
(N. Weiskopf et al., 2013). If completeness was thought of as overall completeness (i.e.,
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the overall number of recorded observations), DQ requirements such as "patients must
have at least X measurements" could be defined. In contrast, completeness is sometimes
thought of in statistical terms, a corresponding requirement could be defined as "the
dataset must contain enough observations to provide adequate statistical power".
Based on these limitations, this framework should possess three features. First, it should
provide a finite list of potential aspects to consider while developing DQ requirements for
a specific dataset and research question. This list should serve as an overview to the DQ
requirement generation process. Second, it should provide a way to bridge domain
knowledge and the DQ requirement generation task. Third, it should list issues and
threats that the requirements should check for in a specific way.
To develop such guidance, I did a preliminary review to define the most frequent analysis
types and clinical data types employed in clinical data reuse projects. I based my work on
a literature review article and a set of clinical data request tickets. I then asked a clinical
expert to define research questions based on their secondary use activities. These served
as use cases. The six final use cases covered 90% of the most common analyses and
clinical data types revealed by the literature review and clinical data request tickets. I
then applied DataGauge to these six use cases in order to answer the following question:
What criteria should be considered when assessing DQ for repurposed clinical data? The
resulting DQ requirements represented a broad range of issues to test for when making
secondary use of clinical data. Based on the generated DQ requirements, I defined an
overview to guide DQ requirement generation in the form of a checklist. This overview
partitions the problem space by knowledge domains and aspects of clinical data to bridge
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the gap between task and domain knowledge. I also provide a list of specific questions to
guide the generation of DQ requirements within each task of the overview checklist. The
questions provide requirement-level guidance to ensure the coverage of specific DQ
issues that may threaten fitness for purpose.
In this chapter I describe the methodology and results of my DQ requirement
development guidance efforts. First, I describe the process used to define six use cases
that cover most applications and data types used in clinical data reuse projects. Then I
describe the methodology that I used to develop the guidance framework based on the
application of DataGauge to these use cases; a presentation of the results follows. I then
describe the general guidance framework and I give an example of its use. Finally, I
discuss the contributions, strengths and limitations of this work as well as future
development directions.
4.1 - Defining Secondary Use Coverage
Clinical data are routinely repurposed for a vast number of applications, so to address our
research question I defined a specific scope. Because covering all possible secondary
uses of clinical data is a monumental endeavor, I limited our scope to uses where clinical
data are reused to answer a specific research question. The set of all possible research
questions that can be answered reusing clinical data is extremely large; therefore, it is
necessary to sample the most representative cases. I chose to cover the most common
analysis types and clinical data types. This will ensure the coverage of the most common
modalities of research and the most frequently used sections of repurposed EHR data
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(i.e., the clinical data types). The research question was: "What are the most common
analyses and clinical data types used for secondary use of clinical data?"
4.1.1 - Methods
I used two data sources to establish a distribution of secondary analysis types and clinical
data types used in clinical data reuse research. First, a systematic review by Song et al.
(Song, Liu, Abromitis, & Schleyer, 2013) that summarized the secondary uses of dental
care data in the literature. Dental EHR records present much overlap with general EHR
so I was able to use these results as a starting point. Variables relevant to the dental
healthcare were not included (e.g., caries activity and periodontics procedure data). I
classified analyses by type and clinical variables used to describe the distribution. The
article defined the clinical variable types. The analysis type categories were defined using
a qualitative grounded theory approach. They were derived from the research questions
reported for every analysis in the literature review. The resulting categories were
outcomes and distribution descriptions, association detection, prevalence estimation,
effect size (e.g., treatment effectiveness) and other. This gave me a preliminary idea of
the most frequently used data and their intended use. Second, I reviewed data requests
submitted to a CDW team. The requests were recoded as service tickets in a tracking
system database for the informatics core of a major healthcare research institution and
served to bridge the gap between dental data and EHR. I reviewed each request and
extracted the required clinical data types as well as the intended secondary analysis type,
when available. I used the same clinical data type categories as for the previous dataset
adding clinical notes, which were often used in this dataset but missing in the review
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article. The considered analysis types were prevalence estimation, distribution, method
validation and other. A large portion of the requests dealt with electronic patient
recruitment (i.e., search of patients corresponding to a specific profile in the EHR
database for potential enrolment in a randomized controlled trial enrolment or clinical
chart review). This category was added as a secondary use type. The frequency of each
analysis and data type was then computed. To confirm the validity of the secondary
analysis categories, a second biomedical informatician independently classified the dental
data analyses from the systematic review and the data request tickets. I used this second
classification to calculate an unweighted Cohen's Kappa measure of inter-observer
reliability.
4.1.2 - Results
The review of secondary uses of dental data (Song et al., 2013) presented 60 publications.
All were included in this review. Then, I reviewed 238 clinical data request tickets
spanning 5 years. 106 requests were excluded because they were misclassified technical
requests (68 items), lacked information on requested variables (22 items), were requests
of data other than clinical data (13 items) or were duplicate requests (3 items).
The distribution of analysis types was similar for both data sources (Figures 3 and 4). We
found that Association studies, Distribution & Outcomes, Prevalence Estimation and
Electronic Patient Recruitment analysis types covered 91.67% of the dental data research
and 96.69% of ticket cases. The inter-observer reliability (i.e. Cohen's Kappa) for the
purpose classification was respectively 0.869 and 0.968 for the dental secondary analyses
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and the data request tickets respectively, which denotes a high level of agreement
between observers and, in turn, a reliable classification. In terms of clinical data types, I
also found similar proportions between the review paper and the data requests (Figures 5
and 6). I found that Demographics, Diagnoses, Appointments, Medications, Labs, Vitals
covered 90.14% of the dental secondary analyses and 96.18% of the clinical data requests
tickets.
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Figure 3 - Distribution of analysis types for dental data reuse analyses. Over 90% of the
analyses are Distribution/Outcome, Association or Prevalence estimation analyses.
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Figure 4 - Distribution of analysis types for clinical data request tickets. Over 90% of the
analyses are Electronic Patient Recruitment, Prevalence Estimation or Distribution
analyses.
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Figure 5 - Distribution of clinical data types for dental data reuse analyses. Over 90% of
the analyses use Demographics, Diagnoses, Appointments, Medications, Vitals and Labs.
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Figure 6 - Distribution of clinical data types for clinical data request tickets. Over 90% of
the analyses use Demographics, Diagnoses, Appointment, Medication, Labs and Vitals
data.
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4.1.3 - Discussion
I was able to define a limited number of analysis types and clinical data types that would
cover over 90% of secondary analyses of clinical data. However, this approach has three
main limitations. First, I reviewed only two data sources. The first one was a literature
review on dental EHRs. I was able to use this review as a viable initial analysis because
dental EHRs have similar data structures to clinical EHRs. The second data source was a
group of unstructured data requests that required qualitative analysis but provided a
broader overview of the types of analyses done for a CDW beyond published analyses.
Thus, the combination of these two data sources provides a reasonable basis to define the
main categories of analysis types and clinical data types used in secondary uses of EHR
data. Second, I did not cover all possible features that define secondary use application.
However, clinical data types and analysis types are two critical aspects that define
secondary use projects and can be generalized across applications. Third, the analysis
types were generated using qualitative grounded theory methods from reviewing research
questions. These categories may not be exhaustive but the data shows that they cover
most cases, leaving only 3% of the analyses in the 'Other' category.
4.1.4 Use-Case Development
After identifying analysis and clinical data types that cover over 90% of secondary use
cases, I developed a set of specific secondary use cases to cover all combinations of these
types. I asked a clinical expert to define research questions serially as they came up in his
research activities. I then developed those research questions into full-fledged use cases
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by including all additional information on assumptions and research design. A short list
of these research questions is presented below; a full description of the use cases can be
found in appendix C. Tables 3 and 4 show the coverage of these use cases across
secondary analysis types and clinical data types.
1. Is the second BP measure statistically lower than the first BP measure taken within a
visit?
2. Are dual BP measurements provider-dependent?
3. How do patient weight measurements vary over time?
4. Is prednisone exposure correlated with weight gain?
5. Are HbA1C lab values correlated with BMI?
6. Can we find patients with BMI>25 and age>21?

59

Table 3 - Secondary analysis type coverage by case. Columns show each case and their
relevant analysis types.

Table 4 - Clinical data type coverage by case. Columns show each case and their relevant
clinical data types.

1

2

3

Demographics
Diagnoses
Appointments
Meds
Labs
Vitals
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4

5

6

4.2 - Method
A data analytics team conducted DQ assessments using DataGauge for the six previously
described use cases. We developed the DQ requirements using the preliminary guidance
(see Table 1) that took into account the DQ dimensions, data granularity levels and DQ
testing approaches. The team was composed of three domain experts: a clinician, a
statistician and a data scientist who also served as a database administrator. We first
generated a data needs model iteratively for each case. The model was discussed
collectively. At least two iterations were carried out for every case. Once the DNM was
established for every research question, we led one-hour interviews with the clinician and
statistician; the team’s data scientist led the interviews. The requirements were encoded
from notes taken during each interview sessions. An approximate total of 20 hours was
spent with each expert to generate the final list of requirements. The final DQ standards
contained a list of DQ requirements for each case. The six final standards represented the
list of minimum requirements for each dataset to be fit for purpose.
Once all requirements were available for each case, I selected dimensions to define an
overview. These dimensions were selected based on their ability to cover the DQ
requirement generation problem space (i.e. the DQ theory, domain knowledge, assessed
data, etc.). This overview would serve as a checklist to ensure that the team generating
the DQ requirements would cover all relevant aspects. The dimensions were chosen to
improve DataGauge's current guidance (see section 3.2.3 for details) by (1) providing an
overview of aspects to cover, (2) bridging the gap between the guidance and clinical
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domain knowledge, while (3) supplying the analytics team with concrete questions to
develop all relevant DQ requirements.
For each sub-section of this overview we listed all relevant requirements and we
generated questions to guide the generation of DQ requirements. These questions aim to
help users to consider all potential flaws relevant to that specific section of the overview.
Providing concrete issues to consider aims to support the generation of DQ requirements
by focusing the expert's attention to known potential threats to fitness for purpose.
Phrasing the guidance in the form of questions forces the analytics team to respond to
specific queries and structure their search around specific interest points rather than
searching a vast problem space. The overview helps the team have a clear idea of the
extent to which potential issues have been covered. An example of the guidance is
described in section 4.4, a full version of the guidance framework (i.e., overview
checklist and question lists) is available in Appendix B.
4.3 - Results
4.3.1 - DQ Requirements Dataset Overview and Descriptive Statistics
Our experts generated 389 requirements across the six cases. Figure 7 shows the
distribution number of requirements by case. These requirements describe features a
dataset must have to be fit for purpose.
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Figure 7 - Distribution of DQ requirements by use case number.
4.3.2 - Guidance Dimensions
The final guidance included four dimensions (Table 5). The two dimensions from the
original DataGauge guidance were preserved. (1) The DQ dimensions as described in
chapter 3 (i.e., correctness, plausibility, completeness, concordance, representation and
timeliness) remained the link to DQ theory. (2) The levels of data granularity (Borek et
al., 2011) (i.e., single value, multiple values, observation, observational unit and dataset)
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remained the primary link in the DNM and reduce complexity. I used these two initial
dimensions to develop the DQ requirements for the six cases. Two new dimensions were
added as the result of the team-based development work. (3) To address the lack of
integration with domain knowledge, I defined a list of knowledge domains. These
directly represent the different areas of expertise necessary to run a secondary use
analysis project and could be mapped to the three expert roles by Barlow (Barlow, 2013).
The clinical expert held knowledge about the clinical/medical science domain and the
clinical workflow. The statistician held the knowledge about the analytical tools and the
research design. The data scientist held the knowledge about data representation and
data manipulation. I also defined an additional research goal knowledge domain
common to all three experts that represents the research question and purpose-specific
considerations. These knowledge domains and their limitations surfaced continuously
during the expert interviews, revealing knowledge gaps between experts as well as the
need for integrated expertise and teamwork. The knowledge domains dimension is useful
to separate out the types of background knowledge to be thought of individually when
generating DQ requirements and allowing to communicate with experts. This also
grounds the DQ generation task by providing some structure. The knowledge domains
dimension contributes to the separation of concerns (Painter, 2006) and contributes to a
more orderly development of DQ requirements. (4) To further ground the guidance to
make it less abstract, while bridging the gap between the evaluated datasets and the
clinical knowledge domain, I defined the clinical data types dimension. I used the same
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clinical data types from those defined in section 4.1 (i.e., demographics, appointments,
diagnoses, prescriptions, lab results and vitals).
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Table 5 - Overview of the four dimensions of our framework for DQ requirement
guidance.
DQ
Dimensions
DQ theory

Levels of Data
Granularity
DNM
integration and
dissection

Elements

Correctness,
Plausibility,
Completeness,
Concordance,
Representation,
Timeliness

Guidance
Need
Addressed

-Connection to
DQ theory

Single value,
Variable,
Observation,
Observational
Unit,
Multiple
Observational
Units,
Dataset
-Provides a way
to break down
the complexity
of datasets
-Provides a way
to examine the
dataset as a
series of
subsets

Source Work

DQ Dimensions
(Wang &
Strong, 1996)
adapted the
secondary use
(Nicole Gray
Weiskopf &
Weng, 2013),
modified in
Chapter 3

Aspects of
DQ
Assessments
Represented

Classification
of DQ testing
approaches
(Borek et al.,
2011; Oliveira
et al., 2005),
adapted in
Chapter 3

66

Knowledge
Domains
Overarching
expertise needs,
Domain
knowledge,
Multidisciplinary
approach
Analytical Tool,
Clinical,
Data
Manipulation,
Representation,
Research Design,
Research Goal,
Workflow

Clinical Data
Types
Data model of
origin, Data
production
considerations,
Clinical domain
knowledge

-Provides an
overview of
relevant areas of
expertise
-Creates a link to
domain
knowledge
-Separates
concerns (Painter,
2006) when
developing DQ
requirements
Expert interviews
(see Section 4.2)
as an extension of
the areas
expertise needed
to carry out
secondary
analyses of data
(Barlow, 2013)

-Reduces
vagueness and
abstraction
-Provides a link
to the assessed
data and the
clinical domain
knowledge

Demographics,
Appointments,
Diagnoses,
Vitals,
Prescriptions,
Lab results

Clinical data
reuse case
definition (see
Section 4.1),
partially based on
(Song et al.,
2013)

4.3.3 - Overview Dimensions and DQ Requirement Generation Contexts
Providing an overview of DQ requirement generation activities is one goals of this new
guidance framework. The utility of an overview is to provide the research team with a list
of aspects to consider when generating the DQ requirements. The knowledge domain
dimension is most fit to serve as a base to build the the framework for four reasons: (1) It
represents the expertise held by the team as a whole, (2) It can be used to allocate
responsibility and separate concerns during the DQ requirement generation (Painter,
2006), (3) Domain knowledge is necessary to carry out every step of the DQ assessment
process and (4) It is the most encompassing and comprehensive dimension.
To identify another dimension that could be included in the overview, I checked whether
the knowledge domain dimension could be paired with any of the other three dimensions.
The goal was to identify a combination that would create separation of concerns (Painter,
2006), while giving a comprehensive overview of the problem space. Ideally, the
combined dimensions would allow DQ requirement generation for every dimension
element combinations (e.g., clinical knowledge and the completeness DQ dimension). I
examined this by creating heat maps the number of DQ requirements generated from the
six use cases for combinations of the knowledge domains and other three dimensions
(Figures 8-9). I found that the generated DQ requirements fully covered the combination
of Knowledge Domains and Clinical Data Types (Figure 9). This means that for every
combination of knowledge domain and clinical data type elements it is possible to
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generate DQ requirements. I refer to the combination of a knowledge domain element
(e.g., clinical domain) and a clinical data type (e.g., vitals) as a DQ requirement
generation context. To emphasize the need to cover each DQ requirement generation
context I converted Figure 9 into a checklist (Table 6). This checklist gives the analytics
team a clear list of all possible DQ generation contexts; each context corresponds to a
checkbox. This overview should help the analytics team to clearly keep track of the
contexts covered during the design of the DQ assessment.

Figure 8 - Distribution of DQ requirements by DQ dimensions and knowledge domain.
The generated requirements fail to cover all sub-sections of this two-dimensional space.
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Figure 9 - Distribution of DQ requirements by data granularity levels and knowledge
domain. The generated requirements fail to cover all sub-sections of this two-dimensional
space.

Figure 10 - Distribution of DQ requirements by clinical data type and knowledge
domain. The generated requirements cover each sub-section of this two-dimensional
space. This makes these two dimensions useful to define a comprehensive problemspace.
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Table 6 - Overview guidance checklist for DQ requirement development. This checklist
partitions the problem-space of DQ requirement development into sub-sections or DQ
generation contexts defined by the knowledge domain (left column) and the clinical data
type (top row). This partitioning provides the analytics team with a clear idea of the
aspects to cover and breaks the complexity of DQ requirement generation into
manageable sub-tasks.
Vitals

Clinical
Analytical Tool
Data Manipulation
Representation
Research Design
Research Goal
Workflow

þ
☐
☐
☐
☐
☐
☐

Demographics Meds

☐
☐
☐
☐
☐
☐
☐

☐
☐
☐
☐
☐
☐
☐

Appointment

Labs

Diagnoses

☐
☐
☐
☐
☐
☐
☐

☐
☐
☐
☐
☐
☐
☐

☐
☐
☐
☐
☐
☐
☐

4.3.4 - Contextual DQ Requirement Generation
The two remaining dimensions (i.e., DQ dimensions and levels of data granularity) were
allocated to provide guidance within each DQ requirement generation context (i.e., the
combination of a knowledge domain and a clinical data type). I provide two sources of
guidance: (1) the original guidance that combines the DQ dimensions and levels of data
granularity as well as (2) a series of context-specific questions generated from the DQ
requirements available from the six use cases. The original guidance provided by the
DataGauge framework (see section 3.2.3) is used to break down the DNM into simpler
data structure at every data granularity level.
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To provide more specific and domain-appropriate guidance, I formulated guidance
questions from the DQ requirements generated for the six use cases for each specific DQ
requirement development context. The role of these questions is to direct the analytics
team's attention to specific threats to fitness for purpose. I classified the questions
according to the evaluated DQ dimensions. Table 7 shows a sample of these of questions
for the clinical knowledge domain and the “Vitals” clinical data type. All levels of
granularity are relevant to all questions if they are represented in the DNM. The data
granularity levels are involved in the process by aiding the DNM decomposition into a
list of pieces for which the domain expert will answer the questions. In the next section I
present an example of the use of this guidance for the development of DQ requirements.
Table 7 - Sample of DQ requirement development guidance questions. These questions
aim to guide the analytics team to address general DQ issues that may be a threat to
fitness for purpose. The team will define DQ requirements based on these questions
taking into account the assessed data and the research question. The resulting
requirements define the features of a dataset that would be fit for purpose. An example of
their use is shown in the following section.
DQ Dimension
Completeness
Completeness
Completeness
Correctness
Plausibility

Guidance Question
Are there enough values to carry out the analysis?
Are all expected vital values present?
Are there any missing values for each vital record?
Are the values within the clinically expected range?
Are all measurements taken after the patient's
date of birth?
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4.4 - DQ Requirement Definition Guidance Example
Within DataGauge, DQ requirements are generated after the research question and the
DNM are defined (see Chapter 3). The DNM defines the relevant clinical data types; all
knowledge domains should be considered for every research question. For this example, I
use the same research question used in Chapter 3: " Is prednisone, a commonlyprescribed corticosteroid, associated with weight gain?" The associated DNM model is
shown in Figure 11. The relevant data types for this specific DNM are Demographics,
represented by the Patient table, Medications, represented by the PrednisonePrescription
table and Vitals, represented by the Weights table. As stated earlier, all knowledge
domains are relevant. The relevant guidance checklist and overview is shown in Table 8.

Figure 11 - Data Needs Model for the research question " Is prednisone, a commonlyprescribed corticosteroid, is associated with weight gain?"
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Table 8 - Overview guidance checklist for the research question " Is prednisone, a
commonly-prescribed corticosteroid, is associated with weight gain?" Clinical data types
are eliminated based on their relevance. In this case, Appointments, Labs and Diagnoses
were not relevant.
Vitals Demographics Meds
Clinical
☐
☐
☐
Analytical Tool
☐
☐
☐
Data Manipulation
☐
☐
☐
Representation
☐
☐
☐
Research Design
☐
☐
☐
Research Goal
☐
☐
☐
Workflow
☐
☐
☐
For a relevant data type, the research team selects a specific knowledge domain and the
questions relevant to that context (i.e., the combination of a clinical data type and
knowledge domain) are retrieved. For our example, we first select the Vitals clinical data
type and the clinical knowledge domain (i.e., the top left checkbox on Table 8). The team
then selects portions of the DNM relevant to the assessed clinical data type. For our
example, the relevant data elements are: the values within the Timestamp, Value and
PatientID variables, these three variables themselves, each observation containing a
combination of Value, Timestamp and PatientID, the Weight table, the combination of
the patient and Weight tables and the whole dataset containing information about vitals,
patients and prescriptions. With this information available, we can then proceed to
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answer the contextual guidance questions for each element of this list. The list of relevant
questions for this requirement generation context is shown on Table 9.

Table 9 - Contextual guidance questions relevant to the clinical domain knowledge and
the Vitals clinical data type. This is the full list of questions available for this context
(i.e., top left check box on Table 7). The full list of questions for the other contexts is
available in Appendix B.
DQ Dimension
Addressed
Completeness
Completeness
Completeness
Completeness
Correctness
Completeness
Correctness
Completeness
Completeness
Correctness
Correctness
Plausibility
Plausibility
Timeliness
Concordance
Concordance
Concordance

DQ Generation Guidance Question
Are all expected vital values present?
Are there any missing values for each vital record?
Do related values have a match? (e.g., systolic + diastolic
blood pressure)
Is the numeric distribution of values and value frequencies
as expected?
Are all values within plausible limits for the population?
Are there an adequate number of measurements within the
desired observation window?
Are the measurements taken after the patient's date of
birth?
Are there sufficient values over time for the analysis?
Is the number of vital measurements as expected? (e.g., at
least one weight measurement per visit)
Is the difference in consecutive values in an encounter
within acceptable range?
Is the difference between variable values between two time
points in acceptable proportion?
Are time stamps in the expected order? (e.g., order before
admin)
Are time stamps within the expected time frame? (e.g.,
BPs measured within the encounter window vs. outside).
Is the time between events of the expected range?
Are there any sudden changes over time? Are they valid?
Are the values coherent or vary as expected within a visit?
Is the overall vital measure variability as expected?
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The combination of a question and the data granularity level DNM pieces (e.g., a weight
value, the weight variable or a weight observation which combines a weight value, a
timestamp and patient ID) may generate one or multiple DQ requirements. For each
question, the expert must consider the research question to inform the definition of
requirements for a fit-for-purpose dataset. For example, when the clinical expert
considers the question "Are all expected vital values present?", which addresses the
completeness DQ dimension, and we are evaluating the weight values, which is a
considered part of the “Vitals” data type, the team may generate requirements such as
"There are adult patients with weights between 50 and 100kg". This is purpose-specific
because the research question (i.e., "Is prednisone, a commonly-prescribed corticosteroid,
is associated with weight gain?") is likely to be answered using adult patient data, given
that children weights increase over time and the prednisone effect may be masked. At the
observation level (i.e., the combination of a weight value, a timestamp and a patientID),
the expert may come up with "All weight values have a timestamp value", which is
necessary to calculate the rate of weight gain to answer the research question.
When considering the guidance question "Are there sufficient values over time for the
analysis?” which addresses the DQ dimension of timeliness, for the timestamp variable
within this same context, the expert may come up with requirements such as "Patients
have at least one weight per encounter" to ensure there is no censoring, "Patients have at
least two weights overall" to be able to calculate the rate of weight change, "Patient has at
least one weight per year between the first and last visit" to ensure reasonable temporal
resolution. When considering the whole dataset, the expert may come up with a
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requirement such as "Patient has at least two measurements within a year of the first
prednisone prescription" to ensure that there is enough data in the timeframe where the
effect is expected.
When considering the question "Are there any sudden changes over time?", which
considers the dimension of concordance, the experts may come up with requirements
such as "Weight within a day should not vary more than X%", "Weights may not vary
more than X% per month" and "Weights may not vary more than X% overall", which
would reveal potentially inaccurate values that may distort relationship value found in the
analysis.
The team will run through the whole list of questions for that specific checkbox and then
move on to the next knowledge domain. When all knowledge domains are covered, the
team moves on to the next relevant clinical data type and repeats the procedure. Once all
clinical data types are reviewed, all checkboxes should be marked. All generated
requirements are aggregated into the DQ standard, which is specific to the research
question and the DNM in question. These requirements define the DQ tests that will yield
the DQ measures to evaluate fitness for purpose within the DataGauge framework.
4.4 - Conclusion
In this chapter, I presented a framework to support the development of DQ requirements
for a specific research question and DNM within DataGauge. The framework addresses
the shortcomings of current guidance available in the literature and the DataGauge
process to enable the systematic generation of DQ requirements. The framework provides
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(1) A clear overview of the issues to be considered while developing DQ requirements
for a specific dataset and research question, (2) A bridge between domain knowledge and
the DQ requirement generation task and (3) A list of specific issues and threats to be
considered in the form of questions.
This framework provides support to the user by providing an overview of the main points
to be considered when assessing DQ. This provides an overarching frame to pose
questions about the appropriateness of a given dataset for a specific purpose. Because of
its dimensions, it supports the separation of concerns (Painter, 2006), which is likely to
provide a more organized and thorough DQ requirement generation. This framework also
addresses the gap between the evaluated data, the domain knowledge and the DQ theory
stated in the literature (Floridi, 2013) and provides an overarching map to ensure
systematic coverage of all concerns. Finally, this framework supports the systematic
definition of DQ requirements. This step is critical because a DQ assessment is the
combination of DQ tests that are directly defined by the DQ requirements. Thus, the
thoroughness of the DQ assessment is directly dependent on the thorough definition of
DQ requirements.
This framework provides an unambiguous checklist and overview to check for issues as a
way to ensure coverage and systematicity. It also provides specific questions as a way to
focus the generation of DQ requirements on specific threats to fitness for purpose.
However, this is an initial framework that does not cover all possible clinical data types
and was developed based on a limited number of cases. Nevertheless, our cases cover the
most broadly used data types and secondary use applications (see section 4.2). A single
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analytics team was involved in the framework's development because we aimed to
develop this initial framework that will be further expanded as other research groups
adopt DataGauge. The guidance checklist provides a development base that is applicable
to other projects as a launching point for future development. Finally, the current version
of the guidance questions may not be phrased in the ideal way. Thus, validation and
further refinement is still necessary and will be part of our future research. This work will
be carried out after the initial DataGauge evaluation described in the following chapter.
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Chapter 5: Evaluation of DataGauge
This chapter presents an evaluation of DataGauge's ability to improve upon the current
state of the art methods of systematic DQ assessment. My hypothesis is that DataGauge
will increase the number of DQ issues flagged for a specific secondary use of clinical
data over the current systematic state of the art method. This evaluation will test
DataGauge's potential usefulness, inform future research directions and identify further
development routes. One particularly interesting aspect in this evaluation is that
DataGauge is one of the first systematic DQ assessment methods to allow a systematic,
fitness-for-purpose approach to the assessment of repurposed clinical data. This sort of
approach has been advocated as the preferred method for DQ assessment in the field of
clinical informatics (Holve et al., 2013), yet a viable candidate is still missing.
Comparing the performance of DataGauge against a general DQ assessment method
would also provide evidence to evaluate the advantage, if any, of a fit for purpose
approach versus a generic one.
In this chapter I describe the process carried out to evaluate DataGauge against a state of
the art DQ assessment method (i.e., the evaluation standard). First, I describe the methods
used for the evaluation, including the rationale for the evaluation standard selection. Then
I present and compare the performance results for DataGauge and the evaluation standard
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over the six cases defined in section 4.2. Finally, I discuss these results and their
implications.
5.1 - Methods
5.1.1 - Defining a DQ Assessment Standard
To evaluate the performance of our assessment method it is necessary to select a control
or baseline method. In most analyses carried out for research purposes some kind of data
cleaning procedure (Broeck & Fadnes, 2013) is carried out by the analyst. This consists
of detecting, diagnosing and rectifying anomalies in the dataset as the analysis
progresses. The main pitfall of this approach is that, being analyst-dependent; there is a
risk of missing errors that threaten the assessment's thoroughness. This is especially
problematic when the data in question are repurposed because an additional set of
complex issues come into play (Hersh et al., 2013; Van Der Lei, 1991). In fact, data
cleaning is geared towards cleaning datasets produced and used for the same purpose
such as randomized controlled trial datasets (Van den Broeck et al., 2005) rather than
repurposed data. An additional pitfall is that, because cleaning happens in parallel to the
analysis, the analyst may find "satisfactory" results from flawed data on first approach
and never question their accuracy. Thus, data cleaning is unlikely to be a reliable
comparison standard.
Though many individual tools are available to test discrete aspects of DQ (Borek et al.,
2011), very few tools are available to carry out whole DQ assessments. However, an
automated tool to assess the DQ in the initial phase of integrating EHR data into a CDW
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is currently available. The Automated Characterization of Health Information at Largescale Longitudinal Evidence Systems (ACHILLES) (G Hripcsak et al., 2015) is a
platform, which enables the characterization, quality assessment and visualization of
observational health databases. ACHILLES was released by the Observational Health
Data Sciences and Informatics (OHDSI) collaborative and provides a module called
ACHILLES Heel (G Hripcsak et al., 2015) that allows the user to automatically detect
database integrity issues and DQ flaws in clinical datasets modelled using the OMOP
common data model (Overhage, Ryan, Reich, Hartzema, & Stang, 2012; Reisinger et al.,
2010). ACHILLES is a state-of-the-art tool to automatically assess DQ in CDWs. It is
capable of detecting issues such as predefined value compliance, limited numeric value
range checks, temporal inconsistencies and data model integrity checks (e.g., primary key
and foreign key check).
Because ACHILLES is an automated, code-based tool, it is capable of consistently
testing all relevant DQ aspects that an expert user with knowledge of the database would
run. This sort of consistency is desirable for a comparison standard or baseline because
the end output would be the same no matter how many tests are run as long as the tested
database remains unchanged. Another virtue of ACHILLES is that, by design, it does not
consider the research question or analytical purpose. One of the limitations of
ACHILLES is that, in its current version, it does not check for statistical outliers.
Statisticians and data analysts routinely use the following rule for outlier detection:
values outside three standard deviations to each side of the mean are considered probable
outliers in normally-distributed data; the range grows to five standard deviations for any
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other kind of distribution (Amidan, Ferryman, & Cooley, 2005; Rahbar et al., 2013). To
address this shortcoming, I supplemented ACHILLES with this outlier detection function.
The final standard of comparison selected for evaluation was the ACHILLES module
supplemented by the statistical outlier detection rule described above.
5.1.2 - Testing Protocol
My test dataset consisted of a teaching outpatient clinic's EHR's database from a major
metropolitan area. This dataset contained 10 years of data for 954,891 patients. The EHR
database was restructured to comply with the Observational Medical Outcomes
Partnership (OMOP) Common Data Model (CDM) Version 5 (G Hripcsak et al., 2015;
Overhage et al., 2012). This enabled me to run the ACHILLES module automatically.
For each test case, I created a new database containing only the data relevant to the
research question. This allowed a complete, yet focused ACHILLES assessment of the
whole database where only issues relevant to the appropriate data would be flagged.
ACHILLES ran automatically on the filtered datasets. To run DataGauge, I coded SQLbased query tests for each requirement generated by experts in the previous experiment
(see Section 4.2 for detailed methods). Each query, I counted the number of violations in
the dataset for the requirement it tested. Each violation flag represented a potential DQ
issue. These counts are the DQ assessment results or DQ measures that quantify the
dataset's adherence to the DQ requirements defined using DataGauge.
Both methods flag requirement violations that could ultimately be a threat to the validity
of analytical results. On one hand, the comparison standard focuses on identifying
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general integrity issues in the dataset. The issues found can be of two kinds: (1) they
could affect the intended use and become a significant data problem or (2) they may not
threaten the purpose directly. These indirect threats are issues that do not jeopardize
answering the research question but may distort the answer if they are too prevalent. On
the other hand, the requirements generated by experts using DataGauge requirements
describe a fit-for-purpose dataset. Therefore, each violation is a potential threat to the
secondary analysis because they represent a shortcoming of the assessed dataset in
relation to the ideal dataset. However, not all requirements represent the same level of
threat to fitness for purpose. To quantify the level of threat, we asked the analytics team
generating the requirements to assign a value to the issue in one of two categories: (1)
Discarding Requirements, which reveal a direct threats to fitness for purpose (e.g., Patient
records that infringe on the requirement "Patient has at least two weight measurements"
for the calculation of weight change over time); (2) Review Requirements, which indicate
a potential flaw that may be rectified via imputation methods or are not a direct threat to
the dataset's fitness for secondary use (e.g., Breaches of "Weight values don't change
more than 2% within a day" should be reviewed and may be potentially corrected using
imputation methods if there are enough values to provide a stable baseline). Each DQ test
from DataGauge had such value assigned during the initial generation. The same
classification process was done for the evaluation standard results for each case.
5.1.3 - Major Differences in DQ Assessment Methods
There are three major differences between the DQ assessment tools that must be taken
into account when interpreting the results. First, the knowledge available when
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generating the test code for each method is different. The evaluation standard (i.e.,
ACHILLES + Outlier detection) is an automated method designed to be broadly
applicable and only taps into knowledge about the data structure. On the other hand, this
standard is easier to use, requiring minimal human effort and involvement because it is
based on executable code. This makes its results reproducible, as they are not based on
human expertise. In contrast, DataGauge benefits from a team of experts and their
knowledge about the data source, the purpose and domain knowledge. This means that
the DQ tests performed by DataGauge should be much more specific and purposeful than
those done by ACHILLES. Second, DataGauge is designed to be purpose-specific,
whereas the standard does not take the purpose into account by design. Therefore, the
issues flagged by the standard may not be a threat to the purpose. To address this, the
issues found by both methods were assigned a level of threat value: discarding
requirements (i.e., direct threats to fitness for purpose) or review requirements (i.e.,
potential flaws that may be rectified via imputation methods or are not a direct threat to
fitness for secondary use). Finally, it is important to note that our comparison standard is
static executable code, whereas DataGauge is based on a set of requirements generated by
a team of experts. This means that the issues flagged by DataGauge are extremely likely
to be relevant threats to the fitness for purpose of the dataset by design (given that each
assessment is tailored to each research question and dataset's needs), whereas the
comparison standard flags issues that are likely to be data flaws without taking the
purpose into account. Therefore, it is necessary to review the issues found by the standard
to confirm their relevancy to assessing fitness for purpose.
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5.2 - Results
I compared the results in three ways. First, I compared the number of issues found by
each method. I show overall performance in flagging potential DQ issues for each
method, followed by a breakdown by DQ requirement severity based on the
requirement's level of threat to fitness for purpose (i.e., discarding vs. review
requirement). I then reviewed the most common DQ issues flagged by both methods to
confirm that the issues found were true DQ issues. Second, I compared the coverage of
each method based on the previously-defined overview dimensions (i.e., clinical data
types and the knowledge domains -see section 4.1) derived from EHR database design
features and types of expertise required for a data reuse project (Barlow, 2013). This
shows the comprehensiveness of each method. Finally, I built a regression model to
predict the number of flags found by each method. I counted the total number of tests
carried out by each method and the total number of tests flagged as positive. I used these
two variables for each method to build a negative binomial to predict the number of
issues found based on the selected methods and the number of test instances. Each case
was considered a separate experiment. All analyses were conducted using R Version
3.2.2 (R Core Team, 2013) assuming statistical significance at p<0·05.
5.2.1 - Number of Flags
Data Gauge flagged roughly ten times more issues than the comparison standard. These
issues represent individual data elements that infringed on a DQ requirement. Overall, the
standard returned 1.4 million flags whereas DataGauge returned 19 million (Figure 12).
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Review flag counts were 1 million flags from the comparison standard versus 9.3 million
for DataGauge (Figure 13). Discarding flag counts showed, 0.4 million for the standard
versus 9.6 million for DataGauge (Figure 13).
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Figure 12 - Number of flags returned by both methods. DataGauge returned close to ten
times more flags than the comparison standard.
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Figure 13 - Number of discarding and review flags returned by both methods.
DataGauge returned close to ten times more review flags than the comparison standard
(left) and close to twenty times more discarding flags (right).
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Reviewing the most common flags revealed multiple overlaps, yet DataGauge included
all flags found by the standard plus more specific issues. Dataset integrity issues were
found by both methods. For example, the control method flagged person, provider and
care site IDs with no correspondence in the table that contained the variables that defined
them (e.g., the demographics table for patients); DataGauge identified the same issues as
primary key-foreign key relationship breaches. Data values were checked by both
methods but DataGauge did this in a more purposeful way. More specifically, the control
method checked for statistical outliers, which provides a knowledge-independent and
broadly applicable way of screening for outliers. These outliers are extremely likely to be
true outliers but the results provide no insight to determine the nature of the DQ issues.
On the other hand, DataGauge flagged values for specific reasons such as vital values out
of range (e.g., Weight measurements over 400kg that are possible but not likely), abrupt
changes over time (e.g., weight changes larger than 10% in the same day) and impossible
timelines (e.g., measurement taken before the patient's date of birth). Beyond these two
categories, DataGauge identified issues that were specific threats to the fitness for
purpose that the control method was unable to flag. For example, patients with
overlapping or co-occurring prescriptions for a research question dealing with drug
exposure and weight variation; the threat to the secondary analysis is that we are unable
to confidently calculate the effective drug exposure because the uncertainty in the drug
exposure timeframe.
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Examining the most common issues for review and discarding requirements confirmed
the drastic difference in test specificity. This confirmed the value of purpose-specific
tests in providing data to evaluate fitness for purpose; review flags clearly showed this
difference. For example, the control method found unidentifiable providers and care sites,
which were marginally threatening to the purpose in most cases, whereas DataGauge
found direct threats to the purpose such as missing covariate data and unexpectedly high
value changes over time. Discarding requirements showed the same differences. The
control method flagged statistical outliers and person IDs that could not be mapped to the
demographics table rendering the record in question unusable. In contrast, DataGauge
found patients without the necessary data to conduct the primary analysis (excluding
covariates), data outside the plausible timeframe, prescriptions with missing values that
prevented the calculation of an effective dose, amongst other issues.
5.2.2 - Coverage of Clinical Data Types and Knowledge Domains
Dimension coverage revealed great differences between methods. DataGauge found
issues in all Clinical Data Types (Figure 14) and Knowledge domains (Figure 15). On the
other hand, the comparison standard failed to identify any issues in two out of six clinical
data types and three out of six knowledge domains. The overview also shows a larger
number of flags on the DataGauge side for every category where both methods returned
flags.
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Figure 14 - Coverage of clinical data types by the control method and DataGauge.
DataGauge covers all clinical data types, whereas the comparison standard fails to flag
any issues for diagnoses and labs. DataGauge also flags more issues for in all data types
covered by both methods.

9,070

10,485

0 1,092,118
4 1,602,378
0

9,082

0 1,657,841
7,054

742,866

Figure 15 - Coverage of knowledge domains by the comparison standard and
DataGauge. DataGauge covers all knowledge domains, whereas the comparison fails to
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flag any issues in three domains. DataGauge also flags more issues in all domains
covered by both methods.

5.2.3 - Statistical Comparison
Statistical comparison of both methods revealed a statistically significant difference
between the two methods when comparing values for only six cases. I compare the
number of issues flagged between DataGauge and the evaluation standard using negative
binomial regression model that accounts for the over-dispersed count data, using the total
number of tests done by each method as an offset variable (Table 10). To account for
potential confounding effects, I compare matched DQ assessment results for a series of
cases (i.e., six matching research question and dataset pairs), where only the applied
method varies. I also explored covariates such as data granularity, analytical unit and DQ
dimension but none of them significantly impacted the estimates of interest . The
expected number of flags returned by DataGauge was significantly higher than the
number returned by standard (Rate Ratio=7.00; 95% CI=[3.22,15.2]; p<0.0001).
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Table 10 – Comparison of the number of flags returned by each method based on
multivariable Negative Binomial regression model . The expected number of flags
returned by DataGauge is almost seven times greater than the number returned by the
control method.
Rate Ratio (95%
p-value
Confidence Interval)
Method

7.00 (3.22,15.2)

<0.0001

5.3 Discussion
DataGauge was able to flag more potential issues than the state of the art method. It
identified more direct threats to the analytical purpose, but also more DQ issues that
could be potentially corrected via review or imputation. This difference was confirmed to
be statistically significant. The issues identified by DataGauge were also more specific,
which allowed for a deeper understanding the dataset's limitations. Finally, DataGauge
showed broader coverage of Knowledge Domains and Clinical Data Types.
This analysis provides evidence of DataGauge's contribution to the current state of the art
but has three main limitations. First, we only used a single clinical database containing
outpatient data. Though this is only one type of clinical data, but is one of the most
broadly available for secondary use. Second, we only assessed DQ for six use cases.
However, we justified their coverage of secondary uses and clinical data types in Chapter
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4. Moreover, these six cases provided adequate statistical power to uncover a statistically
significant difference between DataGauge and the comparison standard. Third, only one
research team was employed in this evaluation, thus the results may not generalize.
Based on these results, I can conclude that DataGauge improves the current state of the
art by improving the detection of DQ issues in two ways. First, DataGauge increases the
number of opportunities to detect DQ issues by providing a broader coverage of the
assessed data and relevant knowledge domains. Second, DataGauge focuses the detection
of specific issues that are directly relevant to the intended secondary use. DataGauge is
the first systematic method to assess DQ in truly fitness-for-purpose-oriented way (Holve
et al., 2013; Juran, 1962). Even though the method is human intensive, the great threats
posed by data repurposing (Hersh et al., 2013; Van Der Lei, 1991) demand such thorough
evaluation. Also, it is currently very difficult to truly assess fitness for purpose in an
automated way given that it requires so much domain knowledge that is not readily
structured. Nevertheless, DataGauge provides an initial systematic process that can
support future automation efforts. Also, when applied thoroughly by a team of experts,
DataGauge is more likely that the current systematic methods to provide a useful body of
evidence to justify or reject the use of a data source for a specific secondary use.
This evaluation provides evidence to confirm that DataGauge improves the current state
of the art. DataGauge builds upon Kahn's framework for pragmatic DQ assessment
framework (M. G. Kahn et al., 2012). It provides practical implementation support for a
previously unavailable fitness for purpose DQ assessment of repurposed clinical datasets
(Holve et al., 2013). It also provides methodological grounding for the implementation of
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the recently published the ontology for the secondary use of clinical data (Johnson et al.,
2015).
These results also encourage the use of fitness for purpose approaches for DQ assessment
of repurposed clinical datasets (Holve et al., 2013) because of their ability to find specific
issues that will encourage or discourage the use of a dataset for a specific purpose.
Though these results are encouraging, a deeper evaluation of the method's usefulness and
utility to real analytics teams is necessary. In this preliminary evaluation I employed
automated methods as a starting point of comparison. However, research teams making
secondary use of data usually carry out additional ad hoc tests and custom data cleaning.
This limitation will be addressed in a future work.
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Chapter 6: Conclusions, Limitations and Contributions
In this dissertation, I have described and evaluated DataGauge, the first systematic yet
purpose-specific procedure for the DQ assessment of repurposed clinical data.
DataGauge addresses current limitations in the state of the art of DQ assessments. It
provides a generalized and systematic way of assessing repurposed clinical data taking
into account the research question for the secondary analysis. Additionally, it makes DQ
assessment parameters explicit, supporting communication within the analytics team and
the transparent reporting of clinical data. I also presented a framework for the
development of DQ requirements within DataGauge, which lists the major concerns to be
checked when repurposing clinical data to promote thorough assessments. This
framework aims to promote comprehensiveness and separation of concerns (Painter,
2006) when designing DQ assessments, which contributes to a thorough and orderly
development of DQ requirements when applying DataGauge. Finally, I evaluated the
DataGauge process comparing it to a current state of the art systematic DQ assessment
method. DataGauge flagged more issues than the evaluation standard, uncovering bigger
threats to fitness for purpose and covering more aspects of the assessed data and
knowledge domains.
DataGauge improves the state of the art by supporting the systematic design and
implementation of DQ assessments taking into account the secondary use purpose or
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research question. Previous DQ assessment methods for the reuse of clinical data have
focused on the application of multiple DQ tools to uncover discrete problems (e.g., typos,
missing values, outliers) (Batini & Scannapieca, 2006b; Maydanchik, 2007a) and have
failed to take the analytical purpose into account. Faulconer and de Lusignan (Faulconer
& de Lusignan, 2004), for example, proposed a statistical procedure to identify DQ
problems generically using mathematical tools rather than assessing potential threats to
achieving the analytical purpose. Hogan and Wagner (Hogan & Wagner, 1997) also
suggested statistical probes to identify specific data issues, but only addressed correctness
and completeness. Kahn et al. (M. G. Kahn et al., 2012) proposed a purpose-based DQ
assessment framework for the reuse of clinical data. However, this framework focuses on
detecting DQ flaws based the data's primary clinical purpose rather than taking analysisspecific considerations into account. Johnson et al. (Johnson et al., 2015) have proposed
an ontology to make DQ measure calculations systematic, but do not provide a way to
select these measures systematically to assess fitness for purpose. Thus, DataGauge is the
first method to address the problem of analysis-specific DQ assessments.
DataGauge is designed to be general enough to support a team of experts to
systematically design and carry out their DQ assessment for any data source and
analytical purpose. However, the development of DQ requirements across analytics teams
is a potential source of inconsistencies. To address this limitation, we have provided a
framework to support the systematic development of DQ standards. We achieve this by
providing a list of potential DQ issues to consider when repurposing clinical data. This
guidance framework is a first step towards supporting the systematic definition of DQ
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requirements. Further development and testing of this framework will be part of my
future work.
The definition of this method and evaluation results have multiple implications. For
clinicians and researchers making secondary use of clinical data, DataGauge
assessments allows for a more trustworthy repurposing of clinical data, by supporting
thorough and purpose-specific assessments before the secondary analysis takes place.
DataGauge also supports the reporting of DQ results by making the DQ assessment
assumptions explicit, and therefore easier to report. DataGauge also promotes a more
thorough assessment of repurposed clinical data because it accounts for the research
question (i.e., the use purpose). This should lead to a better understanding of the
limitations of repurposed clinical data and, in turn, the analytical results. Informaticians
will benefit from this work by having a systematic way of assessing the quality of clinical
data that is fully integrated with the data extraction process. DataGauge offers a
streamlined way of integrating multiple workflows into a single process. This means that
the work of the analytics team making secondary use of clinical data, the CDW team
running the data extraction and the DQ assessment work are harmonized into a single
workflow. The process is also supported by a set of documents that make assumptions
explicit and may improve communication within and beyond the analytics team.
DataGauge may also support the development of design tools and interfaces for
secondary use and data extraction. Such tools are currently available but provide little to
no support for DQ assessment.
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6.1 - Limitations
While DataGauge was shown to flag more potential DQ issues than the current state of
the art method, there are a number of limitations to this work. The DataGauge process
presents four main limitations. First, we do not provide guidance in terms of the number
of iterations to reach satisfactory specifications as this depends on multiple factors such
as analysis type, data needs and research goals. This must, therefore, be left to expert
judgment. Second, DataGauge is tailored to support analysis-specific DQ assessments
and therefore, assumes that the input dataset has been a pre-cleaned to meet the DQ
standards expected from a CDW. Third, DataGauge is human-intensive because the
exhaustive definition of DQ requirements and their testing require considerable effort.
Also, in its current state, DataGauge requires custom coding for the testing of every DQ
requirement, which is much more time consuming than the fully automated evaluation
standard. However, the great threats that arise from data repurposing (Hersh et al., 2013;
Van Der Lei, 1991) demand thorough evaluations that are often not detectable using
automated data checks. Finally, DataGauge only focuses on assessing defined by the
DNM and data contained in the analytical dataset rather than all potentially relevant data
in the CDW. Nevertheless, there are currently no other ways of defining analysisspecific data needs and quality requirements in a consistent way, which makes
DataGauge a valuable tool for the clinical research informatics community.
The guidance framework to support DataGauge presents four main limitations. First, it
may not include all relevant dimensions. Generating all relevant DQ requirements
depends on many aspects of the data, their intended use and their meaning, yet the
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dimensions included are the ones found to be most significant from our research
experience. Second, the comprehensive nature of the framework may lead to the
generation of redundant DQ requirements. Third, the framework, in its current state, may
tax users with a large number of questions for DQ requirement generation. Therefore, it
may not be practical for day-to-day DQ assessment projects. Refinement and testing of
this guidance framework will be done in future work. Finally, though it interfaces with
other DQ frameworks (Johnson et al., 2015; M. Kahn et al., 2015; M. G. Kahn et al.,
2012) , it may be useful to integrate them in future work as well.
The evaluation of DataGauge presents four limitations. First, the evaluation was based on
a single clinical database containing outpatient data. Though this is only one type of
clinical data it is one of the most broadly available for secondary use and one database is
a reasonable starting point for an initial evaluation. Second, a limited number of cases
were used for the development of the guidance framework and evaluation. Still, these
cases were justified to cover over 90% of secondary uses and clinical data types. Third,
only two experts were interviewed to develop the DQ requirements that served as the
basis to develop the guidance framework the evaluation. This is acceptable because the
method is still in its early stages of development and this evaluation was preliminary in
nature. Finally, the ideal comparison standard for the evaluation of DataGauge would
have been a naive research team using their habitual cleaning methods. However, this
option was impractical in our current setting for three reasons: (1) finding research teams
willing to adopt a new, untested technique can be challenging, (2) including a human
element in the evaluation process would introduce much variability in the results and
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would, therefore, require a much larger sample size and (3) the funding needed to run
such study was not currently available. DataGauge is in its early stages of its
development and, thus, a proof of concept evaluation against the current state of the art
tools is prudent and will inform future research. Thus, we chose to use a standardized
baseline method that would minimize the involvement of humans and maximize the
feasibility and repeatability of the evaluation.
6.2 - Contributions
DataGauge contributes to the current state of the science in three ways. First, it advances
applications by supporting more through checks of repurposed clinical data and enabling
their systematic yet purpose-specific DQ assessment. Such checks are necessary because
repurposed clinical data may not be appropriate for their intended secondary purpose
(Van Der Lei, 1991). This work lays the practical foundation for the systematic DQ
assessment of repurposed clinical data as an evaluation of fitness for purpose (Holve et
al., 2013). This contributes to support the reliable secondary use of clinical data (Charles
Safran et al., 2007), which is a critical step towards building learning healthcare systems
(Institute of Medicine (US) Roundtable on Evidence-Based Medicine, 2007). Second,
DataGauge has been shown to improve upon the current state-of-the-art systematic DQ
assessment method by providing a systematic yet purpose-specific approach. This new
assessment methodology flags more potential issues than an alternative automated
approach. It also improves current methods and practices by promoting the explicit
definition of DQ assessment requirements (M. Kahn et al., 2015; M. G. Kahn et al., 2012)
and data extraction parameters. These explicit definitions also show promise in enabling
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a smoother data extraction process through the definition of explicit requirements. In our
experience, data extraction is the source of much inefficiency and 'back and forth'
between the analytics teams and database administrators this is partly due to the
ambiguity of requests, usually submitted as plain text descriptions. Providing a standard
for the explicit definition of data extraction requirements, such as the DNM, can
eliminate much inefficiency by improving communication. The explicit definition of DQ
requirements is also a contribution to current practices given that transparent reporting of
DQ results is a current route of development in the field (M. Kahn et al., 2015), yet no
applied methodological support to such practices is found in the literature. Also, explicit
DQ requirements have the potential to set the groundwork for automated DQ assessment
in the future. Lastly, my work contributes to the field of biomedical informatics by
providing a preliminary inventory of concerns and potential issues to be checked while
making secondary use of clinical data. The guidance framework provides a list of
knowledge domains that ensure all expertise needed for the secondary use of data is
accounted for. The guidance framework and, more specifically, the overview checklist
supports the separation of concerns (Painter, 2006) in DQ requirement generation tasks.
The principle of separation of concerns is responsible the orderly and modular design of
current computer programs. I anticipate that this framework and overview based on this
principle will be a first step towards an orderly and modular generation of DQ
requirements. This is particularly important because of the complexity involved in the
generation of DQ requirements, which stems from the multiple sources of information to
be taken into account for a specific dataset and research question. This guidance also
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promotes a team-based (Barlow, 2013) definition of requirements that is desirable, yet
poorly supported by current practices (Broeck & Fadnes, 2013).
6.3 - Future Work
Future work will consist of further testing and development of the DataGauge and the
guidance framework. DataGauge will be tested with analytics teams making secondary
use of clinical data. An evaluation where a control group uses their native methods to
clean their datasets and an experimental group applies the DataGauge procedure will be
carried out. The DQ results for each group will be compared. Also, I will further expand
the guidance framework by exploring more secondary use cases. Finally, the DataGauge
process will be iteratively improved and streamlined based on end-user feedback.
Because DataGauge is intentionally designed to require considerable human input, I plan
to develop and evaluate tools to support analytical teams as they work through the
process, much as software engineers and programmers now use a number of different
tools to capture requirements, track changes, and track issues.
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Appendix A: Definitions
Data: "A datum is a putative fact regarding some difference or lack of uniformity within
some context." (The Philosophy of Information, 2013) In other words, data are discrete,
atomic answers to specific questions about an object of interest.
Clinical Data: Discrete, atomic answers to specific questions about a patient's health
status and healthcare procedures. In this dissertation, I refer to clinical data as all data
recorded in an electronic health record.
Quality: "The totality of features and characteristics of a product or service that bear on
its ability to satisfy stated or implied needs" (Standardization, 1994)
Data Quality: A dataset's ability of satisfying the needs for a specific purpose (Holve et
al., 2013) (i.e., fitness for purpose (Juran, 1962))
Purpose: "Something set up as an object or end to be attained" (The Merriam-Webster
Dictionary, n.d.). We refer to purpose in this dissertation as the use of data to answer a
specific research question.
Initial purpose: The purpose for which the data are first produced; also known as the
production purpose (Floridi, 2012, 2013).
Data Repurposing: Using data for any purpose other than for which they were
produced(de Lusignan & Mimnagh, 2006; Van Der Lei, 1991).
Secondary Purpose or Secondary use: Any use of data other than the use for which
they were collected; also known as the analytical or secondary purpose(Botsis,
Hartvigsen, Chen, & Weng, 2010; Floridi, 2012, 2013; C. Safran, 2014).
Criterion: "A standard on which a judgment or decision may be based or a
characterizing mark or trait" (The Merriam-Webster Dictionary, n.d.). For this
dissertation, I define a criterion is a axis of interest upon which a value of adequacy can
be assigned, an evaluation can be carried out or a decision can be made.

120

DQ criterion: A point of interest upon which a dataset's fitness for a specific use can be
evaluated. The evaluation will provide a degree of adequacy for the use in relation to a
specific criterion. Each criterion defines a sub-feature of the overall fitness for purpose.
DQ requirement: A condition describing a specific feature that must be respected by a
dataset in order to be fit for a specific use or purpose. Each requirement defines a specific
sub-feature of the overall fitness for purpose. Requirements describe the desirable aspect
for a dataset in the light of a criterion, which is defined by the intended use. DQ
requirements define the minimum expectation on data values to ensure that a specific
dataset is valid and useful for a specific analytical purpose. They aim to define a "fit-forpurpose" dataset in a specific case.
DQ Standard: In this dissertation, I refer to DQ standard as the combination of all DQ
requirements for a specific dataset and intended use. DQ standards are not
interchangeable and must be generated in the light of domain knowledge, the available
data and the intended purpose or research task.
Inclusion/Exclusion Criteria: We differentiate DQ requirements from
Inclusion/Exclusion criteria by the object they define and their goal. Inclusion/Exclusion
criteria define the subjects that qualify for the study based on demographic and clinical
considerations; they aim to define a patient population. For example, "patient is at least
18 years old" is an inclusion criterion whereas "patient date of birth is earlier than
observation date" is a DQ requirement.
DQ rule: "Data quality rules are constraints that validate data relationships and can be
checked using computer programs" (Maydanchik, 2007a). In this dissertation I refer to
DQ rules as an explicit, unambiguous limits that are easily encoded into machineexecutable code to automatically flag infringing data within the assessed datasets. We
differentiate them from DQ requirements by their unambiguous and formal (Morton,
1999) nature.
DQ test: A practical tool, algorithm, approach or strategy employed to test the adherence
of a dataset to a specific DQ requirement or the breach of a DQ rule. They serve as a
means to gather evidence of a dataset's fitness for purpose for a specific DQ criterion.
DQ Assessment: A judiciously selected combination of DQ tests based on DQ
requirements to assess a dataset's fitness for a specific analytical purpose based on
clinical, data science and analytical tool knowledge.
DQ assessments vs. DQ tests: A DQ assessment is a combination of DQ tests designed to
evaluate whether a dataset is fit for a specific purpose. DQ requirements and DQ rules
define the parameters necessary to run the DQ tests.
Data Needs Model: An explicit, unambiguous external representation of the minimal
data needed to achieve a specific research task or goal. In this dissertation, data needs
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model refers to a tidy-data-compliant (Wickham, 2014) UML model (Demuth &
Hussmann, 1999) of the minimal clinical data required to answer a specific research
question.
Research Question Analysis: To define all objects of interest in light of a specific
research question. In this dissertation, I refer to research question analysis as the steps
taken to determine the clinical objects (e.g., patients, prescriptions, labs, etc.), which must
necessarily be known to answer the research questions. From these objects are derived
the variables that are likely to contain the necessary information to answer the research
question via secondary analysis. For example, if our research question is "Is Prednisone
exposure related to weight gain?" we will need information about the patients, their
prednisone prescription history and their weight measurement values. Within these three
objects we will then define the variables to describe then. For example, a patient may be
described by a patient identifier, a date of birth and a gender variable.
Data extraction: Selection of all data that may be relevant to a specific research
question that is transformed to fit a specific data needs model and subsequently used for
DQ evaluation and analysis.
DQ evaluation: The implementation of all DQ tests (based on the DQ standard) into
machine-executable code to detect violations of the predefined DQ requirements. Their
goal is to provide evidence to support the analytics team's decision on the dataset's fitness
for purpose. Each DQ evaluation is specific to a research question, a data needs model, a
DQ standard and an extracted dataset.
DQ results: They are the quantitative evidence of infringement of DQ requirements
within a given dataset for a specific purpose. They usually take the form of counts,
percentages or true/false flags and serve to support the expert's decision about a dataset
being fit or unfit for a specific purpose. They can be assimilated to DQ measures as
described by Johnson et al. (Johnson et al., 2015). In this dissertation, I represented all
DQ results as infringement counts or flag counts.
Separation of concerns: "The ability to identify, encapsulate and manipulate only those
parts of software that are relevant to a particular concept, goal, or purpose” (Ossher &
Tarr, 2001). In other words, it is the ability of teasing out the different pieces of the
puzzle interacting in a task. In the task of generating DQ requirement, multiple sources of
information are at play as well as multiple sources of knowledge (i.e., domain experts). In
this case, the separation of concerns is the definition of an information structure or
framework that delineates the role and interactions of each information and knowledge
source. The guidance framework described in Chapter 4 provides such structure.
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Appendix B: DQ Requirement Development Guidance
In this Appendix I present the details of the guidance framework introduced in Chapter 4.
The framework is composed of two parts: (1) the Data-Knowledge checklist and (2) the
guidance questionnaires. The Data-Knowledge checklist serves as an overview of all
possible contexts (i.e., the combination of a clinical data type and a knowledge domain)
that must be assessed to ensure a thorough DQ assessment design. For each DQ
requirement generation context (i.e., the combination of a knowledge domain and a
clinical data type instance), the framework assigns a guidance questionnaire that presents
all relevant concerns in the form of questions to assess DQ dimension. Each question is
used as a focus to generate DQ requirements around that specific point of interest taking
as inputs a specific Data Needs Model piece at a specific data granularity level (e.g., a
value, an observation, a variable, etc.) and a specific Research Question. The DQ
requirements should aim to define the ideal dataset for the Research Question or
Research Goal. Once the analytics team has addressed all pertinent questionnaires and the
checklist is full, it can be assumed that there is reasonable coverage of potential DQ
issues in repurposed clinical data.
Data-Knowledge Requirements Development Checklist
The Data-Knowledge checklist serves as an overview of the different contexts to be
covered for a thorough DQ assessment design (see table below). Two dimensions define
it: (1) the Clinical Data Types, which are sub-sections of the electronic medical record
and (2) the Knowledge Domain, which represent the different types of knowledge
necessary to carry out a secondary analysis of clinical data. Thus, we can refer to
contexts as the combination of specific elements from these to dimensions. For example,
Appointment data type and Analytical Tool would be the first context in the table below.
Addressing all combinations between all elements between these two dimensions ensure
systematicity through thorough coverage of all relevant issues. It is recommended that
research teams work in groups with all experts present in the room. The Research
Question and the Data Needs Model should be visible to all and consulted as part of the
process. It is suggested that the team work their way through the checklist by breaking
the Data Needs Model down for a Clinical Data Type at all relevant Data Granularity
Levels, then running thought the questionnaires each knowledge domain and finally
move on to the next Clinical Data Type. This will facilitate cross-domain thought and
dialog between the experts, while keeping the evaluated target (i.e., the DNM pieces)
stable during DQ requirement generation.
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Knowledge Domain

Clinical Data
Types:
Analytical Tool
Clinical
Data
Manipulation
Representation
Research Design
Research Goal
Workflow

Appointmen Demographic
t
s
þ
☐
☐
☐

Diagnose
s
☐
☐

Lab
s
☐
☐

Med
s
☐
☐

Vital
s
☐
☐

☐

☐

☐

☐

☐

☐

☐
☐
☐
☐

☐
☐
☐
☐

☐
☐
☐
☐

☐
☐
☐
☐

☐
☐
☐
☐

☐
☐
☐
☐

Question-Driven DQ Requirement Definition
The guidance questionnaires correspond to specific contexts; that is, a specific
combination of Knowledge Domain and Clinical Data Type (e.g., Analytical Tool and
Appointment). For each context, the analytics team will identify the relevant subset of the
Data Needs Model and break them down in as many possible pieces for every Data
Granularity Level (i.e., value, variable, observation, observational unit, multiple
observational units and dataset). They will then address each question for a specific DNM
piece in the frame of a specific Knowledge Domain. These features are the DQ
requirements. Once the team has answered every question, they may move on to the next
context and answer its questionnaire. It is important that the team keep in mind the
research question throughout this work in order to generate requirements that define a fit
for purpose dataset. A full example of the use of this guidance is described in section 4.4.
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Contextual Questionnaires In Alphabetical Order

1. Appointment
1.1. Analytical Tool
DQ
Question
Dimension
Tool
Are all statistical assumptions met by the data?
Limitations
Tool
Can you assume independence between observations?
Limitations
Completeness Are there enough observations within the timeframe of interest to run
the analysis?
Completeness Are there enough patients with all relevant variables within the
timeframe of interest to run the analysis?
Completeness Are there enough observations to provide appropriate statistical power?
Completeness Is the censorship rate acceptable?
Completeness Are the measurements recorded at reasonably regular intervals?
Completeness Are there gaps in recording within the timeframe of interest?
Correctness
Are there duplicate observations?
Completeness Are there enough data points by appointments?
Completeness Are there enough data points by patient and/or care provider?
1.2. Clinical
DQ Dimension
Plausibility
Timeliness

Guidance Question
Is the appointment date within a plausible timeframe?
Is the time between appointments in the expected range?

1.3. Data Manipulation
This Knowledge Domain is beyond DQ dimensions and requirements. Good data
management practices should prevent any DQ issues in this context, yet it is
recommended to verify that no issues arose from extraction. At this stage, the data
scientist designs tests and fail-safes to avoid corrupting the dataset during the data
manipulations and extract-transform-load (ETL) procedures and/or identify them once
the data has been extracted. One example such issues is the creation of duplicates when
using joins. To avoid such issues, the data base administrator should verify the counts
after every join to ensure no duplication has taken place. These checks are usually done
before the dataset is extracted and assessed for DQ. DQ requirements are not necessary
beyond the tests defined by the data scientist but could still be defined for thoroughness
purposes.
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1.4. Representation
DQ Dimension Guidance Question
Representation
Are all Primary Keys unique?
Representation
Do all foreign keys correspond to one primary key?
Representation
Are all values formatted appropriately or as expected?
Representation
Are all values of the right sort (e.g., character, numeric, etc.)?
Representation
Are all predefined values (i.e., concepts) found in the
dictionary? (e.g., ICD-9)
Representation
Are all defined concepts of interest found in the dataset? (e.g.,
if the concept 'male' is defined to be used in the gender variable,
the variable should contain 'male' values)
1.5. Research Design
DQ Dimension
Guidance Question
Completeness
Are any of variables needed for the analysis missing?
Completeness
Are there missing values?
Completeness
Are there values missing not at random?
Completeness
Are there enough values within the desired time range?
Completeness
Is the analytical observational unit (i.e., the main outcome
variable, dependent variable and covariates in one table line)
complete?
Completeness
Is the censorship level for each variable of the observational
unit acceptable?
Correctness
Does the observational unit follow the ideal timeline of
collection? (e.g., vitals are recorded on visit days)
Completeness
Is the rate of censorship acceptable? Are there enough
encounters per patient for the designated research design?
Completeness
Are the missing values spread randomly over time?
Correctness
Does the distribution of demographics correspond to
population estimates at large? (i.e., is the sampling random?)
Completeness
Are the data accessible for analysis? (e.g., are the data not
locked in the clinical notes)
Completeness
Is the ratio of censorship acceptable (i.e., # missing data/#
available data)?
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1.6. Research Goal
DQ Dimension
Guidance Question
Completeness
Are the appointment records complete?
Plausibility
Is the age of patient plausible at the appointment time?
Correctness
Does the appointment record map to a single patient?
Correctness
Is there at least one appointment per patient?
1.7. Workflow
DQ Dimension
Concordance
Concordance
Concordance
Correctness
Timeliness
Correctness

Guidance Question
Are all providers found and defined in the providers table?
Are all locations found and defined in the care sites table?
Are all provider occupations as expected? (e.g., no medical
assistants prescribing drugs)
Are time stamps in the expected order? (e.g., order before
admin).
Are time stamps within the expected time frame? (e.g., BPs
measured within the encounter window vs. outside)
Is the time between events of the expected range?

2. Demographics
2.1. Analytical Tool
DQ Dimension
Guidance Question
Tool Limitations Are all statistical assumptions met by the data?
Tool Limitations Can you assume independence between observations?
Completeness
Are there enough observations within the timeframe of interest?
Completeness
Are there enough patients with all relevant variables within the
timeframe of interest?
Completeness
Are there enough observations to provide appropriate statistical power?
Completeness
Is censorship at an acceptable rate?
Completeness
Are the measurements recorded at reasonably regular intervals?
Completeness
Are there gaps in recording within the timeframe of interest?
Concordance
Are there duplicate observations?
Completeness
Are there enough data points by encounter?
Completeness
Are there enough data points by patient and/or care provider?
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2.2. Clinical
DQ Dimension
Correctness
Completeness
Correctness
Plausibility

Guidance Question
Is gender Male, Female or Unknown?
Does race contain all expected values? In the
expected proportions?
Are ages within inclusion criteria, non-negative
and below 130?
Are all dates of birth later than Jan 1st 1900?

2.3. Data Manipulation
This Knowledge Domain is beyond DQ dimensions and requirements. Good data
management practices should prevent any DQ issues in this context, yet it is
recommended to verify that no issues arose from extraction. At this stage, the data
scientist designs tests and fail-safes to avoid corrupting the dataset during the data
manipulations and extract-transform-load (ETL) procedures and/or identify them once
the data has been extracted. One example such issues is the creation of duplicates when
using joins. To avoid such issues, the data base administrator should verify the counts
after every join to ensure no duplication has taken place. These checks are usually done
before the dataset is extracted and assessed for DQ. DQ requirements are not necessary
beyond the tests defined by the data scientist but could still be defined for thoroughness
purposes.
2.4. Representation
DQ Dimension Guidance Question
Representation
Are all Primary Keys unique?
Representation
Do all foreign keys correspond to one primary key?
Representation
Are all values formatted appropriately or as expected?
Representation
Are all values of the right sort (e.g., character, numeric, etc.)?
Representation
Are all predefined values (i.e., concepts) found in the
dictionary? (e.g., ICD-9)
Representation
Are all defined concepts of interest found in the dataset? (e.g.,
if the concept 'male' is defined to be used in the gender variable,
the variable should contain 'male' values)
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2.5. Research Design
DQ Dimension
Guidance Question
Completeness
Are there missing variables?
Completeness
Are there missing values?
Completeness
Are the values missing not at random?
Completeness
Are there enough values within the desired time range?
Completeness
Is the observational unit defined for the analysis complete? (i.e., are all
necessary variables present)
Completeness
Is the censorship level for the analytical unit observational unit
acceptable? (i.e., are there enough values for the analysis overall)
Correctness
Does the observational unit follow the ideal timeline of collection?
Completeness
Are the missing values spread randomly over time?
Correctness
Does the distribution of demographics correspond to population estimates
at large? (i.e., is the sampling random?)
Completeness
Are the data accessible for analysis? (e.g., the data are not locked in
clinical notes)
Completeness
Is the ratio of censorship acceptable (i.e., # missing data/# available
data)?
2.6. Research Goal
DQ Dimension Guidance Question
Completeness
Are the demographics records complete? (e.g., patients have gender, date
of birth and race values)
Completeness
Does the demographic data have null values?
Plausibility
Is the age of the patient plausible? (e.g., not over 150 years and not
negative)
Correctness
Do values map to a single patient?
Concordance
Are the patient demographics coherent with issue of interest? (e.g., no
pregnant males)
2.7. Workflow
DQ Dimension Guidance Question
Completeness
Are the demographics records entered within the expected observation
timeframe? (e.g., data entered during a visit)
Completeness
Are there missing values in the demographics data of interest?
Plausibility
Is the age of the patient plausible?
Completeness
Does the patient have the minimum data available to fully describe each
visit? (e.g., weight and BP must be taken for every visit as good practice)
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3. Diagnoses
3.1. Analytical Tool
DQ Dimension Guidance Question
Tool
Are all statistical assumptions met by the data?
Limitations
Tool
Can you assume independence between observations?
Limitations
Completeness
Are there enough observations within the timeframe of interest?
Completeness
Are there enough patients with all relevant variables within the
timeframe of interest?
Completeness
Are there enough observations to provide appropriate statistical power?
Completeness
Is censorship at an acceptable rate?
Completeness
Are the measurements recorded at reasonably regular intervals?
Completeness
Are there recording gaps within the timeframe of interest?
Correctness
Are there duplicate observations?
Completeness
Are there enough data points by encounter?
Completeness
Are there enough data points by patient and/or care provider?
3.2. Clinical
DQ Dimension
Completeness
Plausibility
Timeliness
Completeness

Guidance Question
Diagnoses of interest appear at least once?
Are all diagnoses recorded after the patient's date of birth?
Are the diagnoses recorded during a visit that falls within the expected
observation timeframe or before the first visit (i.e., medical history)?
Are diagnoses recorded at regular intervals in the timeframe of
interest?

3.3. Data Manipulation
This Knowledge Domain is beyond DQ dimensions and requirements. Good data
management practices should prevent any DQ issues in this context, yet it is
recommended to verify that no issues arose from extraction. At this stage, the data
scientist designs tests and fail-safes to avoid corrupting the dataset during the data
manipulations and extract-transform-load (ETL) procedures and/or identify them once
the data has been extracted. One example such issues is the creation of duplicates when
using joins. To avoid such issues, the data base administrator should verify the counts
after every join to ensure no duplication has taken place. These checks are usually done
before the dataset is extracted and assessed for DQ. DQ requirements are not necessary
beyond the tests defined by the data scientist but could still be defined for thoroughness
purposes.
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3.4. Representation
DQ Dimension Guidance Question
Representation
Are all Primary Keys unique?
Representation
Do all foreign keys correspond to one primary key?
Representation
Are all values formatted appropriately or as expected?
Representation
Are all values of the right sort (e.g., character, numeric, etc.)?
Representation
Are all predefined values (i.e., concepts) found in the
dictionary? (e.g., ICD-9)
Representation
Are all defined concepts of interest found in the dataset? (e.g.,
if the concept 'male' is defined to be used in the gender variable,
the variable should contain 'male' values)
3.5. Research Design
DQ Dimension
Guidance Question
Completeness
Are there missing variables?
Completeness
Are there missing values?
Completeness
Are the values missing not at random?
Completeness
Are there enough values within the timeframe of interest?
Completeness
Is the analytical observational unit complete?
Completeness
Is the censorship level for the analytical observational unit acceptable?
Correctness
Does the observational unit follow the ideal timeline of collection?
Plausibility
Is the censorship rate acceptable?
Correctness
Are missing values spread randomly over time?
Correctness
Does the distribution of demographics correspond to population estimates
at large (i.e., is the sampling random)?
Completeness
Are the data accessible for analysis? (i.e., are the data not locked in
clinical notes?)
3.6. Research Goal
DQ Dimension
Guidance Question
Concordance
Are there diagnoses that conflict or interact with the
phenomenon in questions?
Timeliness
Are there comorbidities at the time of the visit of interest?
Completeness
Are the diagnoses of interest present?
Concordance
Do the diagnoses evolve as expected?
Completeness
Is the ratio of censorship acceptable (i.e., # missing data/#
available data)?
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3.7. Workflow
DQ Dimension
Timeliness
Concordance
Plausibility
Correctness
Completeness

Guidance Question
Are there conflicting diagnoses overlapping in time?
Are there duplicate diagnoses?
Are all diagnoses recorded after patient's data of birth?
Are the diagnoses within the expected observational
timeframe?
Are there diagnoses of interest within the desired timeframe?

4. Labs
4.1. Analytical Tool
DQ Dimension Guidance Question
Tool
Are all statistical assumptions met by the data?
Limitations
Tool
Can you assume independence between observations?
Limitations
Completeness
Are there enough observations within the timeframe of interest?
Completeness
Are there enough patients with all relevant variables within the
timeframe of interest?
Completeness
Are there enough observations to provide appropriate statistical power?
Completeness
Is censorship at an acceptable rate?
Completeness
Are the measurements recorded at reasonably regular intervals?
Completeness
Are there recording gaps within the timeframe of interest?
Correctness
Are there duplicate observations?
Completeness
Are there enough data points by encounter?
Completeness
Are there enough data points by patient and/or care provider?
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4.2. Clinical
DQ Dimension
Completeness
Completeness
Completeness
Completeness
Completeness
Completeness
Plausibility
Completeness
Correctness
Plausibility
Plausibility
Plausibility
Plausibility
Concordance
Concordance
Concordance
Completeness
Completeness
Correctness
Completness

Guidance Question
Are all expected lab values present?
Are there any missing values for each lab record? (e.g., value
with timestamp)
Do matching values have a match? (e.g., lipid panel)
Is the distribution of values distribution as expected?
Are the values within limits for the population?
Are there enough measurements within the expected observation
window?
Are the labs dated after the patient's date of birth?
Are there sufficient values over time for the analysis?
Is the frequency of lab values as expected?
Is the difference in consecutive measurements in an encounter
within acceptable range?
Is the difference in consecutive measurements within an
acceptable range of than the average difference for the
individual?
Is the difference between variable values between two time
points in acceptable proportion?
Are there any sudden changes over time? Are they valid?
Are the values coherent or vary as expected within a visit?
Is the overall vital measure variability as expected?
Are there statistical outliers?
Are there timestamps at regular intervals within expected
observation timeframe?
Lab results contain positive, negative and numeric values?
Is the temporal frequency of labs as expected for a patient?
Is the temporal density as expected for the population?

4.3. Data Manipulation
This Knowledge Domain is beyond DQ dimensions and requirements. Good data
management practices should prevent any DQ issues in this context, yet it is
recommended to verify that no issues arose from extraction. At this stage, the data
scientist designs tests and fail-safes to avoid corrupting the dataset during the data
manipulations and extract-transform-load (ETL) procedures and/or identify them once
the data has been extracted. One example such issues is the creation of duplicates when
using joins. To avoid such issues, the data base administrator should verify the counts
after every join to ensure no duplication has taken place. These checks are usually done
before the dataset is extracted and assessed for DQ. DQ requirements are not necessary
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beyond the tests defined by the data scientist but could still be defined for thoroughness
purposes.
4.4. Representation
DQ Dimension Guidance Question
Representation
Are all Primary Keys unique?
Representation
Do all foreign keys correspond to one primary key?
Representation
Are all values formatted appropriately or as expected?
Representation
Are all values of the right sort (e.g., character, numeric, etc.)?
Representation
Are all predefined values (i.e., concepts) found in the
dictionary? (e.g., ICD-9)
Representation
Are all defined concepts of interest found in the dataset? (e.g.,
if the concept 'male' is defined to be used in the gender variable,
the variable should contain 'male' values)
4.5. Research Design
DQ Dimension
Guidance Question
Completeness
Are there missing variables?
Completeness
Are there missing values?
Completeness
Are the values missing not at random?
Completeness
Are there enough values within the timeframe of interest?
Completeness
Is the analytical observational unit complete?
Completeness
Is the censorship level for the observational unit acceptable?
Correctness
Does the observational unit follow the ideal timeline of collection?
Correctness
Are missing values spread randomly over time?
Correctness
Does the distribution of demographics correspond to population estimates
at large? (Is the sampling random?
Completeness
Are the data accessible for analysis? (e.g., are the data not locked in
clinical notes?)
Completeness
Is the ratio of censorship acceptable (i.e., # missing data/# available
data)?
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4.6. Research Goal
DQ Dimension
Guidance Question
Completeness
Are the lab results complete and with adequately recorded
values?
Completeness
Does the lab result contain all expected values?
Correctness
Are the lab values in the expected format and unit?
Completeness
Does the data have null values?
Correctness
Is the age of patients plausible at the time of the lab?
Correctness
Do labs correspond to a single patient?
Timeliness
Are there enough values within the desired timeframe?
Completeness
Does the patient have enough data once non-compliant
values have been eliminated?
Concordance
Are there sudden changes in values over time?
Concordance
Are the values of interest coherent with the patient's history?
Is it a potential outlier?
4.7. Workflow
DQ Dimension
Concordance
Concordance
Plausibility
Completeness

Guidance Question
Are there overlapping labs? Do they present disparate values?
Are there duplicate labs?
Are the labs recorded after patient's date of birth?
Are there enough labs within the desired timeframe?

5. Meds
5.1. Analytical Tool
DQ Dimensions
Guidance Question
Tool Limitations
Are all statistical assumptions met by the data?
Tool Limitations
Can you assume independence between observations?
Completeness
Are there enough observations within the timeframe of interest?
Completeness
Are there enough patients with all relevant variables within the
timeframe of interest?
Completeness
Are there enough observations to provide appropriate statistical power?
Completeness
Is censorship at an acceptable rate?
Completeness
Are the measurements recorded at reasonably regular intervals?
Completeness
Are there gaps in recording within the timeframe of interest?
Correctness
Are there duplicate observations?
Completeness
Are there enough data points by encounter?
Completeness
Are there enough data points by patient and/or care provider?
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5.2. Clinical
DQ Dimension
Completeness
Completeness
Completeness
Concordance
Concordance
Completeness
Correctness
Correctness
Plausibility
Plausibility
Correctness
Correctness
Correctness
Correctness
Correctness
Correctness
Plausibility
Plausibility

Guidance Question
Does the dataset contain prescriptions of the drug of interest?
Are numeric values within the expected range?
Is the sig complete for all prescriptions?
Are there overlaps between prescriptions?
Are there multiple prescriptions of the same drug at the same
time?
Is a drug exposure variable calculable from the available data
for every prescription?
Is the dose of medications prescribed in multiples of the
commercially available strength?
Is the daily dose within an acceptable range?
Is the number of refills within an acceptable range?
Does the total quantity dispensed match the duration and
dose prescribed?
Is the total quantity dispensed within an acceptable dose
range for the medication?
Is the number of days prescribed within an acceptable range?
Is days>0 and <200?
Are all strength values>0 and <[max commercial strength]?
Are doses>0 and <2*[max daily dose]?
Are refills>=0 and <10?
Is total quality=days*dose?
Is total quantity>0 and <600?

5.3. Data Manipulation
This Knowledge Domain is beyond DQ dimensions and requirements. Good data
management practices should prevent any DQ issues in this context, yet it is
recommended to verify that no issues arose from extraction. At this stage, the data
scientist designs tests and fail-safes to avoid corrupting the dataset during the data
manipulations and extract-transform-load (ETL) procedures and/or identify them once
the data has been extracted. One example such issues is the creation of duplicates when
using joins. To avoid such issues, the data base administrator should verify the counts
after every join to ensure no duplication has taken place. These checks are usually done
before the dataset is extracted and assessed for DQ. DQ requirements are not necessary
beyond the tests defined by the data scientist but could still be defined for thoroughness
purposes.
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5.4. Representation
DQ Dimension Guidance Question
Representation
Are all Primary Keys unique?
Representation
Do all foreign keys correspond to one primary key?
Representation
Are all values formatted appropriately or as expected?
Representation
Are all values of the right sort (e.g., character, numeric, etc.)?
Representation
Are all predefined values (i.e., concepts) found in the
dictionary? (e.g., ICD-9)
Representation
Are all defined concepts of interest found in the dataset? (e.g.,
if the concept 'male' is defined to be used in the gender variable,
the variable should contain 'male' values)
5.5. Research Design
DQ Dimension
Guidance Question
Completeness
Are there missing variables?
Completeness
Are there missing values?
Completeness
Are the values missing not at random?
Completeness
Are there enough values within the timeframe of interest?
Completeness
Is the analytical observational unit complete?
Completeness
Is the censorship level for the observational unit acceptable?
Correctness
Does the observational unit follow the ideal timeline of collection?
Plausibility
Is the censorship rate acceptable?
Correctness
Are the missing values spread randomly over time?
Correctness
Does the distribution of demographics correspond to population estimates
at large? (i.e., is the sampling random)
Completeness
Are the data accessible for analysis? (e.g., are the data locked in the
notes)?
Completeness
Is the ratio of censorship acceptable (i.e., # missing data/# available
data)?
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5.6. Research Goal
DQ Dimensions
Guidance Question
Completeness
Does the prescription contain the medication of interest?
Correctness
Does the prescription correspond to a patient?
Concordance
Are there medications that interact with the drug of interest?
Concordance
Are there simultaneous prescriptions? Of the same drug?
Concordance
Are there overlapping prescriptions?
Concordance
Are there prescriptions that interact with the phenomenon of
interest?
Completeness
Is it possible to calculate an effective dose?
Concordance
Are the prescriptions renewed? Stopped?
Concordance
Are the prescriptions coherent with the diagnoses?
Completeness
Are there diagnoses, vitals or other clinical data available at the time
of prescription?
Completeness
Is the sig complete?
Timeliness
Are there enough patients with prescriptions in the timeframe of
interest?
5.7. Workflow
DQ Dimension
Concordance
Completeness
Plausibility
Timeliness
Completeness
Concordance

Guidance Question
Are there overlapping prescriptions?
Are the prescriptions renewed?
Are the prescriptions recorded after patient's date of birth?
Are the prescriptions within the expected observational time?
Are there prescriptions within the desired timeframe?
Are the prescriptions recorded during a visit or encounter?
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6. Vitals
6.1. Analytical Tool
DQ
Guidance Question
Dimension
Tool
Are all statistical assumptions met by the data?
Limitations
Tool
Can you assume independence between observations?
Limitations
Completeness Are there enough observations within the timeframe of interest?
Completeness Are there enough patients with all relevant variables within the
timeframe of interest?
Completeness Are there enough observations to provide appropriate statistical power?
Completeness Is censorship at an acceptable rate?
Completeness Are the measurements recorded at reasonably regular intervals?
Completeness Are there gaps in recording within the timeframe of interest?
Correctness
Are there duplicate observations?
Completeness Are there enough data points by encounter?
Completeness Are there enough data points by patient and/or care provider?
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6.2. Clinical
DQ Dimension

Guidance Question

Completeness/
Correctness
Completeness/
Correctness
Completeness/
Correctness
Completeness/
Correctness
Completeness/
Correctness
Concordance
Concordance
Concordance

Is the numeric distribution of values and value frequencies as
expected?
Is the number of vital measurements as expected? (e.g., at least
one weight measurement per visit)

Correctness
Correctness
Correctness
Correctness
Completeness
Correctness
Timeliness
Timeliness

Do related values have a match? (e.g., systolic + Diastolic)
Are there any missing values for each vital record?
Are there an adequate number of measurements within the
desired observation window?
Is the overall vital measure variability as expected?
Are there any sudden changes over time? Are they valid?
Are the values coherent or vary as expected within a visit?
Is the difference in consecutive values in an encounter within
acceptable range?
Is the difference between variable values between two time points
in acceptable proportion?
Are the measurements taken after the patient's date of birth?
Are all values within plausible limits for the population?
Is the time between events of the expected range?
Are time stamps within the expected time frame (e.g., BPs
measured within the encounter window vs. outside).
Are time stamps in the expected order? (e.g., order before admin).
Are there sufficient values over time for the analysis?

6.3. Data Manipulation
This Knowledge Domain is beyond DQ dimensions and requirements. Good data
management practices should prevent any DQ issues in this context, yet it is
recommended to verify that no issues arose from extraction. At this stage, the data
scientist designs tests and fail-safes to avoid corrupting the dataset during the data
manipulations and extract-transform-load (ETL) procedures and/or identify them once
the data has been extracted. One example such issues is the creation of duplicates when
using joins. To avoid such issues, the data base administrator should verify the counts
after every join to ensure no duplication has taken place. These checks are usually done
before the dataset is extracted and assessed for DQ. DQ requirements are not necessary
beyond the tests defined by the data scientist but could still be defined for thoroughness
purposes.
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6.4. Representation
DQ Dimension Guidance Question
Representation
Are all Primary Keys unique?
Representation
Do all foreign keys correspond to one primary key?
Representation
Are all values formatted appropriately or as expected?
Representation
Are all values of the right sort (e.g., character, numeric, etc.)?
Representation
Are all predefined values (i.e., concepts) found in the
dictionary? (e.g., ICD-9)
Representation
Are all defined concepts of interest found in the dataset? (e.g.,
if the concept 'male' is defined to be used in the gender variable,
the variable should contain 'male' values)
6.5. Research Design
DQ Dimensions Guidance Question
Completeness
Are there missing variables?
Completeness
Are there missing values?
Completeness
Are the values missing not at random?
Completeness
Are there enough values within the desired time range?
Completeness
Is the observational unit defined for the analysis complete?
Completeness
Is the censorship level for the observational unit acceptable?
Correctness
Does the observational unit follow the ideal collection timeline?
Completeness
Is the ratio of censorship acceptable (i.e., # missing data/# available
data)?
Completeness
Are the missing values spread randomly over time?
Correctness
Does the distribution of demographics correspond to population estimates
at large? (i.e., is the sampling random?)
Completeness
Are the data accessible for analysis? (e.g., is the data locked in clinical
notes)
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6.6. Research Goal
DQ Dimensions Guidance Question
Completeness
Are the vital records complete?
Completeness
Does each observation contain all specific measurements required
for analysis?
Completeness
Does the data set have null values for ideal analytical observation
unit?
Plausibility
Is the age of patient plausible at the time of measurement?
Correctness
Do vital observations map to a single patient?
Timeliness
Are there enough values within the desired timeframe?
Completeness
Does the patient have enough data once the record is cleaned?
Concordance
Are there sudden changes in values over time?
Concordance
Is the value of interest coherent with the patient's history? Is it a
potential outlier?
6.7. Workflow
DQ Dimension
Completeness
Plausibility
Correctness
Plausibility
Concordance
Concordance
Completeness
Concordance
Correctness

Guidance Question
Are there vitals for every observation year?
Are all measures after the patient's date of birth?
Are the measures within the expected observation range?
Are all expected vital measures within each encounter? (e.g.,
routinely recorded values such as weight, BP, etc.)
Is the provider the same for all measures within the encounter?
Are all readings for the same visit entered within an hour of each
other for outpatient data?
Is the measurement rate as expected for repeated measures?
Do matched measurements have the same caregiver? (e.g., systolic
and diastolic)
Do patients have more measurements than expected?
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Appendix C: Use Case Definitions
Case 1- Duplicate BP measurements
Goal: Use of a CDW to assess whether there is a difference between blood pressure (BP)
measurements when a repeated measures protocol is in place.
Research Question: Is the second BP measure statistically lower than the first BP
measure taken within a visit?
Hypothesis: Subsequent BP measurements (second, third, etc.) are lower than the first BP
measurement taken during that visit.
Possible Analyses:
Linear Regression model- Predict 2nd BP value based on 1 BP value (used for validation)
Linear Regression model 2- Outcome Variable = Difference between BP measurements
GEE or mixed effect model (repeated measures)- for multiple data points
Final Data Needs Model:
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Case 2- Caregiver relationship to BP measurements
Goal: Describe the number of blood pressure recordings by caregivers along visit units to
assess the relationship, if any, between the caregiver and the implementation of the
double measurement blood pressure protocol.
Research Question: Are dual BP measurements provider-dependent?
Hypothesis: There is a relationship between the number of BP measurements recorded
and the caregiver's background, training and occupation.
Analysis:
Logistic GEE or mixed model - Accounts for patient-level correlation and covariates.
Main outcome variable= 2 BP measurements per visit? Binary Variable (yes/no)
Final Data Needs Model:
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Case 3- Observational study of weight trends in population
Goal: Identify and describe the types trends in the weight changes of patients from the
point of view of an outpatient clinic.
Research Question: What are the modes of variation of weight values over time?
Hypothesis: There are district patterns of weight evolution over time that depend on the
patient's demographic and health information.
Possible Analyses:
Sparkline, trend line and line plot visualization techniques.
Linear regression for adjusted mean weight.
Final Data Needs Model:
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Case 4- Relationship between drug intake and side effect
Goal: Identify the relationship between prednisone and weight gain in clinical care data.
Research Question: 4. Is prednisone exposure correlated with weight gain?
Hypothesis: There is a positive relationship between prednisone exposure and weight
change over time.
Possible Analysis:
GEE regression model predicting weight change over time after first prescription based
on prednisone exposure levels.

146

Case 5-Relationship between BMI and HbA1c lab values
Goal: Identify and describe the relationship between BMI and HbA1C and glucose lab
test results.
Research Question: Are HbA1C lab values correlated with BMI?
Hypothesis: Patients with higher BMI have higher glucose and HbA1C readings
Analysis:
Linear Regression predicting HbA1c values based on BMI values
Final Data Needs Model:
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Case 6-Recruiting patients with BMI>25 and age>21
Goal: Identify patients with the following characteristics: BMI>25 and age>21
Research Question: Can we find patients BMI>25 and age>21?
Hypothesis: N.A.
Analysis: N.A.
Final Data Needs Model:
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